Media Coverage

Search and Filter
Search by Date Search by Date
Scientific Divisions Scientific Divisions
Results per Page:
  • 5
  • 10
  • 20
  • 50
  • 100
  • all

A new study links sugary drinks with disease. The reality is more complicated

The Seattle Times cited Dr. Mario Kratz about the health impact of sugary beverages.

The Seattle Times

Fred Hutch researchers map how bird flu jumps to humans

GeekWire covered Fred Hutch Dr. Jesse Bloom’s recent study looking at how the bird flu travels to humans. 

GeekWire

Tech Moves: Madrona Venture Labs staffs up; Washington State Opportunity Scholarship executive director departs; and more

GeekWire highlighted Drs. Nancy Davidson and Denise Galloway recent induction into the Academy of Arts and Sciences, a scholarly society that began in 1780. 

GeekWire

High-deductible health policies linked to delayed diagnosis and treatment

Dr. Veena Shankaran, co-director of Fred Hutch’s health care and economics policy research group, the Hutchinson Institute for Cancer Outcomes Research, commented on the impact of high-deductible health plans on people with cancer. She said, “high-deductible plans are really the epitome of the access-to-care problem. People don't have the liquid cash to meet their deductible, so you see delays in care or even avoiding treatment altogether.”

NPR

How you can climb the spire on top of the Space Needle

KING 5 aired a story on the Base 2 Space fundraising event that benefits Fred Hutch.

KING 5

Ex-Bristol R&D Chief to helm Seattle cancer center

 Dr. Thomas J. Lynch shared some of his top goals for Fred Hutch as its incoming president and director. 

The Wall Street Journal
January 07, 2020

Scientists link mysterious snippets of DNA to cell growth and tumor suppresion

Dr. Rob Bradley discussed the importance of poison exons and tumor suppression. 

GeekWire
January 07, 2020

Taking supplements during breast cancer treatment increase risk of death and relapse, what does this mean for patients?

Dr. Kevin Cheung provided expert commentary on the relationship between breast cancer and nutritional supplements. 

Forbes
January 06, 2020

Leaving the reservation for higher education: The story of two brothers

Great Falls Tribune profiled Josh Marceau and his path to Fred Hutch.  

Great Falls Tribune
January 02, 2020

CAR T-cell therapy in pediatric ALL

OncLive featured Dr. David Maloney in a panel on CAR T-cell therapies for pediatric ALL. 

OncLive
December 23, 2019

Barbie puts on a lab coat and finds formula to win holiday diorama contest at Seattle’s Fred Hutch

Graeme Black of Fred Hutch’s immunology program commented on the idea behind his “Winterfest” diorama contest entry.   

GeekWire
December 20, 2019

Now & then: Grown-up Joey Hutchinson’s fire is ‘all part of the legacy’

Joey Hutchinson, grandson of Fred Hutchinson, discussed his family’s legacy.

The Seattle Times
December 20, 2019

How one common immune cell prevents checkpoint inhibitors from attacking cancer

FierceBiotech covered Dr. McGarry Houghton’s study on neutrophils and checkpoint inhibitors.

FierceBiotech
December 20, 2019

Fred Hutchinson is researching new cancer treatments in the cloud with AWS

Dr. Raphael Gottardo discussed how machine learning can help his work in immunotherapy research. 

Diginomica
December 18, 2019

Don’t call me Karen, Cheryl, Nancy, Reshma, Cornelia, Caryn, Sharon, …call me “Doctor”.

Dr. Nancy Davidson shared  her experiences with gender bias in oncology.  

The Cancer Letter
December 13, 2019

Thin metal films loaded with immune cells show promise as cancer therapy

Dr. Matthias Stephan commented on his research on CAR T-cell delivery systems. 

GeekWire
December 09, 2019

Why didn’t we hatch from eggs? Thank viruses, says biologist

Dr. Harmit Malik discussed his research on retroviruses. 

KNKX
December 07, 2019

Gary Gilliland: Seattle has ‘extraordinary potential’ to be a leader in cancer research

Dr. Gary Gilliland shared his views on the future of Fred Hutch. 

Puget Sound Business Journal
December 06, 2019

A new study says hair dyes and chemical straighteners may cause cancer

Dr. Anne McTiernan provided expert commentary on the relationship between hair dyes and cancer.

Forbes
December 04, 2019

An HIV vaccine by 2021? Here is what needs to happen

Forbes detailed the current status of HIV trials, including those conducted by the HIV Vaccine Trials Network, which is headquartered at Fred Hutch.

Forbes
December 03, 2019

Cancer sends many patients into bankruptcy. Advisors are stepping up to stop that

Dr. Veena Shankaran shared her insights about the financial burden of cancer care. 

CNBC
November 24, 2019

Lung-MAP trial reveals genetic testing knowledge gaps among patients

Dr. Joshua Roth discussed his study on genetic testing knowledge.

Cure Today
November 20, 2019

Melanoma rates falling sharply among teens and young adults, UW study finds

KOMO News covered a recent study between Fred Hutch and UW researchers that found that melanoma rates are decreasing in young adults. 

KOMO News
November 13, 2019

Lung cancer rates among women are falling much slower than those in men. Here’s why

Dr. Alice Berger commented on the possible roles of genetics in lung cancer prevalence among women who do not smoke. 

TIME
November 07, 2019

Denise Galloway helped pave the way for the HPV vaccine

Dr. Denise Galloway shared some career highlights as part of winning a 2019 Women of Influence Award.

Puget Sound Business Journal
November 07, 2019

From cancer patient to medical crusader: Fred Hutch researcher shares her journey

Dr. Kristin Anderson shared her personal story about what led her to study immunology in ovarian cancer.

King 5 News
November 06, 2019

How clinical trials are leading to breakthroughs in cancer treatments

Dr. Damian Green discussed the importance of clinical trials. 

King 5 News
November 05, 2019

Hormone therapy for breast cancer

Dr. Hannah M. Linden provided expert commentary on hormone therapy. 

U.S News & World Report
November 04, 2019

How Washington keeps America sick and fat

Dr. Mario Kratz commented on clinical nutrition research funding.

Politico
November 04, 2019

The Health 202: cancer patients have steep expenses beyond treatment. This rock band is trying to help.

Washington Post Dr. Anne McTiernan provided expert commentary on cancer risk factors. 

Washington Post
October 18, 2019

The Health 202: cancer patients have steep expenses beyond treatment. This rock band is trying to help.

Washington Post Dr. Anne McTiernan provided expert commentary on cancer risk factors. 

Washington Post
October 18, 2019

Vaginal fluid transplants hold promise but raise safety concerns

Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.

Scientific American
October 16, 2019

Vaginal fluid transplants hold promise but raise safety concerns

Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.

Scientific American
October 16, 2019

Fred Hutch scientists on how gold nanoparticles could bring CRISPR to the developing world

GeekWire featured Dr. Jennifer Adair’s research on CRISPR and gold nanoparticles.

GeekWire
October 10, 2019

Fred Hutch scientists on how gold nanoparticles could bring CRISPR to the developing world

GeekWire featured Dr. Jennifer Adair’s research on CRISPR and gold nanoparticles.

GeekWire
October 10, 2019

ElevateBio founds HighPassBio to develop Fred Hutch cell therapy

FierceBiotech highlighted new spinout HighPassBio, founded by Hutch researcher Marie Bleakley.

FierceBiotech
October 01, 2019

Seattle researchers seeking volunteers for breast cancer study

KING 5 highlighted a current study led by Dr. Anne McTiernan looking at the effects of exercise on breast cancer.

KING 5
October 01, 2019

Why the women most likely to die of breast cancer have gotten the least attention

Time included expert commentary from Dr. Cyrus Ghajar on metastatic breast cancer.

Time
October 01, 2019

Why the women most likely to die of breast cancer have gotten the least attention

TIME included expert commentary from Dr. Cyrus Ghajar on metastatic breast cancer.

Time
October 01, 2019

ElevateBio founds HighPassBio to develop Fred Hutch cell therapy

FierceBiotech highlighted new spinout HighPassBio, founded by Hutch researcher Marie Bleakley.

FierceBiotech
October 01, 2019

Seattle researchers seeking volunteers for breast cancer study

KING 5 highlighed a current study led by Dr. Anne McTiernan looking at the effects of exercise on breast cancer.

KING 5
October 01, 2019

Gift to Fred Hutchinson Cancer Research Center fueling push to cure pediatric cancer

KIRO 7 featured Fred Hutch’s efforts in pediatric cancer research.

KIRO 7
September 25, 2019

GeekWire Summit: Health tech innovators to discuss gene editing; AI; telemedicine; and more

GeekWire highlighted Dr. Jennifer Adair’s talk on gene editing at the GeekWire Summit.

GeekWire
September 25, 2019

Milestones in Medicine: How Immunotherapy Began in Cancer Care

Cure featured Dr. Phil Greenberg’s research on T-cell receptor therapies. 

Cure
September 25, 2019

GeekWire Summit: Health tech innovators to discuss gene editing; AI; telemedicine; and more

GeekWire highlighted Dr. Jennifer Adair’s talk on gene editing at the GeekWire Summit.

GeekWire
September 25, 2019

Milestones in Medicine: How Immunotherapy Began in Cancer Care

Cure featured Dr. Phil Greenberg’s research on T-cell receptor therapies. 

Cure
September 25, 2019

Gift to Fred Hutchinson Cancer Research Center fueling push to cure pediatric cancer

KIRO 7 featured Fred Hutch’s efforts in pediatric cancer research.

KIRO 7
September 25, 2019

Dr. Lyman on challenges with biosimilar policies

 Dr. Gary Lyman, senior lead of health care quality and policy at Fred Hutch, provided expert commentary on biosimilar policies.

OncLive
September 24, 2019

Dr. Lyman on challenges with biosimilar policies

 Dr. Gary Lyman, senior lead of health care quality and policy at Fred Hutch, provided expert commentary on biosimilar policies.

OncLive
September 24, 2019

HIV vaccine shows signs of cross-subtype protection

FierceBiotech featured a Fred Hutch study suggesting cross-subtype immune response against HIV in South Africa.

FierceBiotech
September 20, 2019

HIV vaccine shows signs of cross-subtype protection

FierceBiotech featured a Fred Hutch study suggesting cross-subtype immune response against HIV in South Africa.

FierceBiotech
September 20, 2019

Life after surviving cancer: the relief, challenges, and new fears

KUOW hosted Laura Landro, WSJ contributor, who discusses her treatment at Fred Hutch.  

KUOW
September 19, 2019

Life after surviving cancer: the relief, challenges, and new fears

KUOW hosted Laura Landro, WSJ contributor, who discusses her treatment at Fred Hutch.  

KUOW
September 19, 2019

Fred Hutch President Gary Gilliland to step down as leader of cancer research powerhouse

GeekWire featured President Gary Gilliland’s statement on stepping down from his role at Fred Hutch.  

GeekWire
September 17, 2019

Dr. Grivas on biomarker for Pembrolizumab response in urothelial cancer

OncLive highlighted Dr. Petros Grivas and his work on urothelial cancer. 

OncLive
September 17, 2019

Dr. Grivas on biomarker for Pembrolizumab response in urothelial cancer

OncLive highlighted Dr. Petros Grivas and his work on urothelial cancer. 

OncLive
September 17, 2019

Fred Hutch President Gary Gilliland to step down as leader of cancer research powerhouse

GeekWire featured President Gary Gilliland’s statement on stepping down from his role at Fred Hutch.  

GeekWire
September 17, 2019

A Patient’s Guide to Acute Lymphoblastic Leukemia

Dr. Ryan Cassaday shared his expertise on Acute Lymphoblastic Leukemia.

U.S. News & World Report
September 09, 2019

Reducing the risk of blood clots in patients with Multiple Myeloma

Cure Today featured Dr. Ang Li’s paper on risk factors for patients with Multiple Myeloma.

Cure Today
September 09, 2019

A Patient’s Guide to Acute Lymphoblastic Leukemia

Dr. Ryan Cassaday shared his expertise on Acute Lymphoblastic Leukemia.

U.S. News & World Report
September 09, 2019

Reducing the risk of blood clots in patients with Multiple Myeloma

Cure Today featured Dr. Ang Li’s paper on risk factors for patients with Multiple Myeloma.

Cure Today
September 09, 2019

Weight loss possible with psychiatric drugs

Anne McTiernan provided expert commentary on a weight loss and psychiatric drug interaction study. 

Reuters
September 05, 2019

Weight loss possible with psychiatric drugs

Dr. Anne McTiernan provided expert commentary on a weight loss and psychiatric drug interaction study. 

Reuters
September 05, 2019

Low-Fat Dietary Pattern Offers Long-Term Health Benefits

HealthDay features Dr. Ross Prentice and the Women’s Health Initiative research on the benefits of long-term benefits of low-fat diets for 

HealthDay
September 04, 2019

Highlights from ASCO’s quality care symposium: A clinical trial may offer the best survival odds for people battling Non-Small-Cell Lung Cancer, but not enough patients enroll in them

Everyday Health highlights Dr. Cristina Merkhofer’s research on how clinical trial participation increases non-small-cell lung cancer survival times.

Everyday Health
September 04, 2019

Low-Fat Dietary Pattern Offers Long-Term Health Benefits

HealthDay features Dr. Ross Prentice and the Women’s Health Initiative research on the benefits of long-term benefits of low-fat diets for 

HealthDay
September 04, 2019

Highlights from ASCO’s quality care symposium: A clinical trial may offer the best survival odds for people battling Non-Small-Cell Lung Cancer, but not enough patients enroll in them

Everyday Health highlights Dr. Cristina Merkhofer’s research on how clinical trial participation increases non-small-cell lung cancer survival times.

Everyday Health
September 04, 2019

Paperwork, high costs could mean worse survival for lung cancer patients

HealthDay highlights Dr. Bernardo Goulart’s work on the impact of high out-pocket costs on the survival of lung cancer patients with certain mutations.  

HealthDay
September 03, 2019

Paperwork, high costs could mean worse survival for lung cancer patients

HealthDay highlights Dr. Bernardo Goulart’s work on the impact of high out-pocket costs on the survival of lung cancer patients with certain mutations.  

HealthDay
September 03, 2019

Seeking Immunity: Exploring Kaposi’s Sarcoma

Dr. Thomas Uldrick provides expert commentary on Kaposi’s sarcoma- associated herpesvirus.

Cure Today
August 30, 2019

Seeking Immunity: Exploring Kaposi’s Sarcoma

Dr. Thomas Uldrick provides expert commentary on Kaposi’s sarcoma- associated herpesvirus.

Cure Today
August 30, 2019

CRISPR slows the growth of triple-negative breast cancer in mice

FierceBiotech references Fred Hutch research on the use of gold nanoparticles to deliver CRISPR edited cells to targeted areas.

FierceBiotech
August 26, 2019

CRISPR slows the growth of triple-negative breast cancer in mice

FierceBiotech references Fred Hutch research on the use of gold nanoparticles to deliver CRISPR edited cells to targeted areas.

FierceBiotech
August 26, 2019

Fred Hutch program inspires teens interested in science

KING 5 News profiled Fred Hutch’s Jeanne Ting Chowning and her work with the Pathway Explorers Program to educate and train the next-generation of scientists.

KING 5
August 21, 2019

What does your waist say about your health? According to a new study, a lot more than you’d think.

The Seattle Times features Dr. Marian Neuhouser’s research on body mass index, waist size and health correlates. 

The Seattle Times
August 21, 2019

Fred Hutch program inspires teens interested in science

KING 5 News profiled Fred Hutch’s Jeanne Ting Chowning and her work with the Pathway Explorers Program to educate and train the next-generation of scientists.

KING 5
August 21, 2019

What does your waist say about your health? According to a new study, a lot more than you’d think.

The Seattle Times features Dr. Marian Neuhouser’s research on body mass index, waist size and health correlates. 

The Seattle Times
August 21, 2019

Fred Hutch program inspires teens interested in science

KING 5 News profiled Fred Hutch’s Jeanne Ting Chowning and her work with the Pathway Explorers Program to educate and train the next-generation of scientists.

KING 5
August 21, 2019

What does your waist say about your health? According to a new study, a lot more than you’d think.

The Seattle Times features Dr. Marian Neuhouser’s research on body mass index, waist size and health correlates. 

The Seattle Times
August 21, 2019

NMSU and University of Washington students learn community health first-hand in rural NM

This article highlights the Health Disparities Field Experience, a 2-week immersive experience for University of Washington graduate students to travel to New Mexico and learn about health disparities in communities in the U.S Southwest. This was the first annual Health Disparities Field Experience sponsored by the Partnership for the Advancement of Cancer Research, a federally funded partnership between NMSU and Fred Hutch. .

New Mexico State News Center
August 16, 2019

NMSU and University of Washington students learn community health first-hand in rural NM

This article highlights the Health Disparities Field Experience, a 2-week immersive experience for University of Washington graduate students to travel to New Mexico and learn about health disparities in communities in the U.S Southwest. This was the first annual Health Disparities Field Experience sponsored by the Partnership for the Advancement of Cancer Research, a federally funded partnership between NMSU and Fred Hutch. .

New Mexico State News Center
August 16, 2019

NMSU and University of Washington students learn community health first-hand in rural NM

This article highlights the Health Disparities Field Experience, a 2-week immersive experience for University of Washington graduate students to travel to New Mexico and learn about health disparities in communities in the U.S Southwest. This was the first annual Health Disparities Field Experience sponsored by the Partnership for the Advancement of Cancer Research, a federally funded partnership between NMSU and Fred Hutch. .

New Mexico State News Center
August 16, 2019

NMSU and University of Washington students learn community health first-hand in rural NM

This article highlights the Health Disparities Field Experience, a 2-week immersive experience for University of Washington graduate students to travel to New Mexico and learn about health disparities in communities in the U.S Southwest. This was the first annual Health Disparities Field Experience sponsored by the Partnership for the Advancement of Cancer Research, a federally funded partnership between NMSU and Fred Hutch. .

New Mexico State News Center
August 16, 2019

Dr. John Hansen, who made marrow transplants safer, dies at 76

The New York Times highlights honored the late-Dr. John Hansen and his contributions to bone marrow transplant research. Note: Subscription required. 

The New York Times
August 13, 2019

Dr. John Hansen, who made marrow transplants safer, dies at 76

The New York Times highlights honored the late-Dr. John Hansen and his contributions to bone marrow transplant research. Note: Subscription required. 

The New York Times
August 13, 2019

Dr. John Hansen, who made marrow transplants safer, dies at 76

The New York Times highlights honored the late-Dr. John Hansen and his contributions to bone marrow transplant research. Note: Subscription required. 

The New York Times
August 13, 2019

Dr. John Hansen, who made marrow transplants safer, dies at 76

The New York Times highlights honored the late-Dr. John Hansen and his contributions to bone marrow transplant research. Note: Subscription required. 

The New York Times
August 13, 2019

Dense breast notification laws not leading to more screening ultrasounds

Reuters highlighted Dr. Christoph Lee’s study, which showed that despite state laws requiring women be notified of dense breast tissue, indicating higher cancer risk, this does not lead to increased screening ultrasound rates. 

Reuters
August 08, 2019

Dense breast notification laws not leading to more screening ultrasounds

Reuters highlighted Dr. Christoph Lee’s study, which showed that despite state laws requiring women be notified of dense breast tissue, indicating higher cancer risk, this does not lead to increased screening ultrasound rates. 

Reuters
August 08, 2019

Dense breast notification laws not leading to more screening ultrasounds

Reuters highlighted Dr. Christoph Lee’s study, which showed that despite state laws requiring women be notified of dense breast tissue, indicating higher cancer risk, this does not lead to increased screening ultrasound rates. 

Reuters
August 08, 2019

Dense breast notification laws not leading to more screening ultrasounds

Reuters highlighted Dr. Christoph Lee’s study, which showed that despite state laws requiring women be notified of dense breast tissue, indicating higher cancer risk, this does not lead to increased screening ultrasound rates. 

Reuters
August 08, 2019

Can an immune strategy used to treat cancer also wipe out HIV infections?

Hans-Peter Kiem provides expert commentary on the application of CART cell immunotherapy for HIV.

Science
August 07, 2019

Can an immune strategy used to treat cancer also wipe out HIV infections?

Hans-Peter Kiem provides expert commentary on the application of CART cell immunotherapy for HIV.

Science
August 07, 2019

Can an immune strategy used to treat cancer also wipe out HIV infections?

Hans-Peter Kiem provides expert commentary on the application of CART cell immunotherapy for HIV.

Science
August 07, 2019

Can an immune strategy used to treat cancer also wipe out HIV infections?

Hans-Peter Kiem provides expert commentary on the application of CAR T cell immunotherapy for HIV.

Science
August 07, 2019

Meet the 30 young leaders who are transforming the future of healthcare and disrupting a $3.5 trillion industry

Emily Silgard was chosen as one of Business Insider’s 30 under 40 awardees. This article highlights her efforts in leading a data science team at Fred Hutch. Note: Subscription required.

Business Insider
August 05, 2019

What we need to do to get more people with cancer into clinical trials

Dr. Joseph Unger provided expert commentary focused on clinical trial participation barriers.

Healthline
August 05, 2019

Meet the 30 young leaders who are transforming the future of healthcare and disrupting a $3.5 trillion industry

Emily Silgard was chosen as one of Business Insider’s 30 under 40 awardees. This article highlights her efforts in leading a data science team at Fred Hutch. Note: Subscription required.

Business Insider
August 05, 2019

What we need to do to get more people with cancer into clinical trials

Dr. Joseph Unger provided expert commentary focused on clinical trial participation barriers.

Healthline
August 05, 2019

Meet the 30 young leaders who are transforming the future of healthcare and disrupting a $3.5 trillion industry

Emily Silgard was chosen as one of Business Insider’s 30 under 40 awardees. This article highlights her efforts in leading a data science team at Fred Hutch. Note: Subscription required.

Business Insider
August 05, 2019

Meet the 30 young leaders who are transforming the future of healthcare and disrupting a $3.5 trillion industry

Emily Silgard was chosen as one of Business Insider’s 30 under 40 awardees. This article highlights her efforts in leading a data science team at Fred Hutch. Note: Subscription required.

Business Insider
August 05, 2019

What we need to do to get more people with cancer into clinical trials

Dr. Joseph Unger provided expert commentary focused on clinical trial participation barriers.

Healthline
August 05, 2019

Reversing sickle cell disease with CRISPR-edited stem cells

FierceBiotech highlights Hans-Peter Kiem’s research on the use of CRISPR to alter genes related to fetal hemoglobin production. 

FierceBiotech
July 31, 2019

Reversing sickle cell disease with CRISPR-edited stem cells

FierceBiotech highlights Hans-Peter Kiem’s research on the use of CRISPR to alter genes related to fetal hemoglobin production. 

FierceBiotech
July 31, 2019

Reversing sickle cell disease with CRISPR-edited stem cells

FierceBiotech highlights Hans-Peter Kiem’s research on the use of CRISPR to alter genes related to fetal hemoglobin production. 

FierceBiotech
July 31, 2019

Seattle mom turns the flight of her life into funds for cancer research

KING 5 News profiled Dr. Damian Green’s work on multiple myeloma with patient and fundraising advocate Sarah Kaufmann- Fink.  

KING 5
July 24, 2019

Seattle mom turns the flight of her life into funds for cancer research

KING 5 News profiled Dr. Damian Green’s work on multiple myeloma with patient and fundraising advocate Sarah Kaufmann- Fink.  

KING 5
July 24, 2019

Seattle mom turns the flight of her life into funds for cancer research

KING 5 News profiled Dr. Damian Green’s work on multiple myeloma with patient and fundraising advocate Sarah Kaufmann- Fink.  

KING 5
July 24, 2019

Ongoing study will examine cardiac toxicity of breast cancer treatment

Cure Today featured Kerryn Reding, a member of the UPBEAT study team, and their research on the cardiovascular effects of breast cancer.  

Cure Today
July 22, 2019

Ongoing study will examine cardiac toxicity of breast cancer treatment

Cure Today featured Kerryn Reding, a member of the UPBEAT study team, and their research on the cardiovascular effects of breast cancer.  

Cure Today
July 22, 2019

Gene found in embryos can cloak cancer from common immunotherapy methods, researchers find

GeekWire highlighted research led by Drs. Robert Bradley and Stephen Tapscott on how a gene normally found in early development, helps cancer cells avoid detection from the immune system. 

GeekWire
July 18, 2019

Gene found in embryos can cloak cancer from common immunotherapy methods, researchers find

GeekWire highlighted research led by Drs. Robert Bradley and Stephen Tapscott on how a gene normally found in early development, helps cancer cells avoid detection from the immune system. 

GeekWire
July 18, 2019

A’s Stephen Piscotty, the 2019 Hutch Award winner, on a mission to find cure for ALS after losing mother

The Seattle Times ran a feature on 2019 Hutch Award winner Stephen Piscotty.

The Seattle Times
July 16, 2019

A’s Stephen Piscotty, the 2019 Hutch Award winner, on a mission to find cure for ALS after losing mother

The Seattle Times ran a feature on 2019 Hutch Award winner Stephen Piscotty.

The Seattle Times
July 16, 2019

The Promise and price of cellular therapies

The July 22 issue of The New Yorker spotlights Fred Hutch’s pioneering research in bone marrow transplantation and how it led to cell therapies using a patient’s own cells. 

The New Yorker
July 15, 2019

The Promise and price of cellular therapies

The July 22 issue of The New Yorker spotlights Fred Hutch’s pioneering research in bone marrow transplantation and how it led to cell therapies using a patient’s own cells. 

The New Yorker
July 15, 2019

Microsoft joins with Pacific NW medical research institutions on data discovery platform

GeekWire covered the Cascadia Data Discovery Initiative, a new collaboration between Fred Hutch and Microsoft to create a shared network of research data. 

GeekWire
July 12, 2019

Microsoft joins with Pacific NW medical research institutions on data discovery platform

GeekWire covered the Cascadia Data Discovery Initiative, a new collaboration between Fred Hutch and Microsoft to create a shared network of research data. 

GeekWire
July 12, 2019

Fred Hutch appoints execs from Amazon and Celgene to board

The Puget Sound Business Journal covered the recent additions to the Fred Hutch board of directors. Sean Boyle from Amazon Web Services, and Dr. Corsee Sanders from Celgene will be added to the board. 

The Puget Sound Buisness Journal
July 10, 2019

Biopsies May Help Guide Treatment for Bladder Cancer

The Cancer Network analyzed Dr. Andrew Hsieh’s study on bladder cancer and rapid autopsies.

Cancer Network
July 10, 2019

Geeking out with a goal: Regina Wu brings Hutch research to classrooms

The Seattle Times profiled Regina Wu, a curriculum designer and educator at Fred Hutch, in its “Cool Jobs” feature.

The Seattle Times
July 10, 2019

Avoid these cancer-causing foods

Dr. Jeannette Schenk commented on what foods people should limit or avoid in order to reduce their cancer risk. 

U.S. News & World Report
July 10, 2019

Fred Hutch appoints execs from Amazon and Celgene to board

The Puget Sound Business Journal covered the recent additions to the Fred Hutch board of directors. Sean Boyle from Amazon Web Services, and Dr. Corsee Sanders from Celgene will be added to the board. 

The Puget Sound Buisness Journal
July 10, 2019

Biopsies May Help Guide Treatment for Bladder Cancer

The Cancer Network analyzed Dr. Andrew Hsieh’s study on bladder cancer and rapid autopsies.

Cancer Network
July 10, 2019

Geeking out with a goal: Regina Wu brings Hutch research to classrooms

The Seattle Times profiled Regina Wu, a curriculum designer and educator at Fred Hutch, in its “Cool Jobs” feature.

The Seattle Times
July 10, 2019

Avoid these cancer-causing foods

Dr. Jeannette Schenk commented on what foods people should limit or avoid in order to reduce their cancer risk. 

U.S. News & World Report
July 10, 2019

The Summer of Fred Hutch

Fred Hutch vice president Kelly O’Brien appeared on KING 5 News to discuss the community events Fred Hutch is organizing over the summer to fund cancer research.

KING 5
July 09, 2019

The Summer of Fred Hutch

Fred Hutch vice president Kelly O’Brien appeared on KING 5 News to discuss the community events Fred Hutch is organizing over the summer to fund cancer research.

KING 5
July 09, 2019

Why this cancer researcher (and survivor) is climbing Kilimanjaro to raise money to study cancer

GeekWire featured Dr. Kristin Anderson, a post-doctoral researcher at Fred Hutch who is climbing Mount Kilimanjaro this summer to raise money for Fred Hutch as part of the Climb to Fight Cancer fundraising effort. 

GeekWire
July 06, 2019

How Fred Hutchinson saved baseball in Seattle

Lookout Landing posted a profile of Fred Hutchinson and his legacy on the field and in the community

Lookout Landing
July 05, 2019

Stored in synapses: How scientists completed a map of the roundworm’s brain

Fred Hutch Dr. Aakanksha Singhvi provided expert commentary on recent research that shows a map the roundworm’s brain and what it means for understanding how brain controls behavior. 

The New York Times
July 03, 2019

Influx of Targeted Therapies Prompts Several Questions in AML Paradigms

OncLive profiled Dr. Mary-Beth Percival about her work using targeted agents to treat patients with acute myeloid leukemia. 

OncLive
July 02, 2019

Who was Fred Hutchinson?

KING 5 Evening aired a feature on Fred Hutchinson’s career and the legacy of his namesake cancer center. 

KING 5
June 28, 2019

Dr. Shadman on challenges with CAR T-cell therapy

Dr. Mazyar Shadman explains that one of the main challenges with CAR T-cell therapy is that there are an increasing number of CAR T-cell therapies, making it difficult for an effective product to stand out. 

OncLive
June 28, 2019

Hutch, the baseball hero and namesake for the cancer research center founded by his brother, was born in Seattle 100 years ago

The Seattle Times’ Pacific NW Magazine dedicated its “Now & Then” feature to Fred Hutchinson honoring what would have been his 100th birthday.

The Seattle Times
June 27, 2019

Lung cancer screening guidelines may miss more African Americans at risk

Dr. Jaimee Heffner provided expert commentary on a new study about lung cancer screening guidelines. This story was re-printed in several other outlets, including Business Insider. 

Reuters
June 27, 2019

Prostate cancer diagnosis may become easier with new urine test

Dr. Ruth Etzioni provided expert commentary about a new urine test to detect prostate cancer. 

Healthline
June 26, 2019

Cost effectiveness of CAR T-Cell therapy depends on long-term outcomes

Dr. Josh Roth provided expert commentary about a study on cost of CAR-T therapy.

Cancer Network
June 23, 2019

Concurrent ibrutinib with CAR T-Cell therapy improves ORR, reduces severe CRS in high-risk CLL

OncLive featured Dr. Jordan Gauthier’s study of a combination immunotherapy for patients with high risk- chronic lymphocytic leukemia (CLL). 

OncLive
June 21, 2019

Phase 1 study demonstrates safety of pembrolizumab in patients with HIV and advanced cancer

American Journal of Managed Care featured Dr. Tom Uldrick’s recent study showing that pembrolizumab is safe in cancer patients with HIV.

American Journal of Managed Care
June 18, 2019

HBV tied to non-liver digestive-tract cancers

MedPage Today highlighted a study led by Fred Hutch’s Dr. Scott Ramsey, which showed that newly diagnosed cancer patients were unaware that they were infected with Hepatitis B and other viruses.

MedPage Today
June 17, 2019

Disrupted gut microbiome promotes breast cancer spread in mice

Dr. Susan Bullman commented on a study about the gut microbiome and breast cancer. 

Forbes
June 11, 2019

Recruiting an Old Drug for a New Purpose in Battle Against Pediatric AML

Dr. Allison Kaeding is featured in a profile piece for her work on pediatric acute myeloid leukemia (AML). 

Oncology Times
June 06, 2019

CRISPR gene-edited babies may be at increased risk of early death, study finds

Fred Hutch Dr. Hans-Peter Kiem, director of the Stem Cell and Gene Therapy Program at Fred Hutch, provided expert commentary on a study about editing genes passed down to offspring. 

CNN
June 05, 2019

Listen: A special episode from the halls of the ASCO meeting

STAT interviewed Dr. Parth Shah on The Readout Loud podcast about his research on increasing HPV vaccination rates in the U.S. 

STAT
June 04, 2019

Genetic mutation that prevents HIV infection tied to earlier death

Dr. Hans-Peter Kiem provided expert commentary on a recent study showing that a genetic mutation of a gene that protects HIV infection is associated with earlier death.

The Scientist
June 03, 2019

Dr. Gary Gilliland on Fred Hutch and Washington commerce

United Airlines’ in-flight magazine interviewed Dr. Gary Gilliland to learn more about Fred Hutch’s work with Microsoft and Amazon to help advance cancer research. 

United Airlines Hemispheres Magazine
June 01, 2019

Local study asks, does a day's exercise fight breast cancer?

Dr. Anne McTiernan shared her expertise on exercise and cancer prevention in a segment that highlighted her new exercise study.

KOMO
May 31, 2019

Protecting against RSV

Reader’s Digest covered Dr. Justin Taylor’s recent study in Science Immunology on B cell engineering. 

Reader's Digest
May 29, 2019

OncLive honors 15 trailblazers with giants of cancer care program

OncLive included Dr. Fred Appelbaum as one of this year’s “Giants of Cancer Care” for his leukemia work. 

Oncology Times
May 28, 2019

Fred Hutchinson team uses gold nanoparticles to improve CRISPR gene editing

Fred Hutch Dr. Jennifer Adair’s recent research published in Nature Materials shows how to use a gold nanoparticle to deliver gene editing machinery to blood stem cells. 

FierceBiotech
May 27, 2019

Health claims in nutrition books can be a ‘volcano of nonsense.’ A new website is fighting back.

Dr. Mario Kratz provided comments on why he reviews the latest nutrition and health books for the Red Pen Reviews website. 

The Seattle Times
May 23, 2019

Historic steam plant in Seattle gets a fresh new look courtesy of Fred Hutch

GeekWire highlighted Fred Hutch’s recent developments to move into the historic Lake Union Steam Plant building. 

GeekWire
May 22, 2019

Piscotty honored as Hutch Award winner

MLB.com covered the news of Oakland A’s outfielder Stephen Piscotty winning the Hutch Award. The news was also published in the San Francisco Chronicle, NBC Sports Bay Area, and the San Jose Mercury News.

MLB.com
May 21, 2019

Genetically engineered immune cells fight off deadly virus in mice

Science covered a B cell engineering study led by Dr. Justin Taylor. 

Science
May 17, 2019

Researchers use gene editing to make cells immune to HIV and other infections in Fred Hutch study

GeekWire covered Fred Hutch Dr. Justin Taylor’s recent work using gene editing to protect against HIV and other viruses. 

GeekWire
May 17, 2019

Seattle skyline to glow orange for National Cancer Research Month

King 5 highlighted Fred Hutch’s ‘Glow Orange to Cure Cancer’ campaign, a week-long campaign where Seattle landmarks and businesses glowed orange for a week in May in honor of National Cancer Research month. 

KING 5
May 07, 2019

Does sleep apnea cause cancer? New evidence suggests women could be at more risk

Dr Amanda Phipps, was interviewed by Survivornet about the association of sleep apnea and cancer risk.

Survivornet
May 06, 2019

Study highlights challenges in using artificial intelligence to personalize cancer treatment

STAT covered Dr. Bernardo Goulart’s study on using artificial intelligence to identify certain lung cancer patients. 

STAT
May 06, 2019

Algorithms help spot cancer ‘lottery winners’ in new Fred Hutch study

GeekWire profiled Fred Hutch Dr. Bernardo Goulart’s recent study on using artificial intelligence to identify lung cancer patients that have certain mutations. 

GeekWire
May 06, 2019

Recruiting an Old Drug for a New Purpose in Battle Against Pediatric AML

Dr. Allison Kaeding is featured in a profile piece for her work on pediatric acute myeloid leukemia (AML). 

Oncology Times
May 05, 2019

A new study links sugary drinks with disease. The reality is more complicated

The Seattle Times cited Dr. Mario Kratz about the health impact of sugary beverages.

The Seattle Times
May 01, 2019

Fred Hutch researchers map how bird flu jumps to humans

GeekWire covered Fred Hutch Dr. Jesse Bloom’s recent study looking at how the bird flu travels to humans. 

GeekWire
April 30, 2019

How you can climb the spire on top of the Space Needle

KING 5 aired a story on the Base 2 Space fundraising event that benefits Fred Hutch.

KING 5
April 26, 2019

Tech Moves: Madrona Venture Labs staffs up; Washington State Opportunity Scholarship executive director departs; and more

GeekWire highlighted Drs. Nancy Davidson and Denise Galloway recent induction into the Academy of Arts and Sciences, a scholarly society that began in 1780. 

GeekWire
April 23, 2019

High-deductible health policies linked to delayed diagnosis and treatment

Dr. Veena Shankaran, co-director of Fred Hutch’s health care and economics policy research group, the Hutchinson Institute for Cancer Outcomes Research, commented on the impact of high-deductible health plans on people with cancer. 

NPR
April 18, 2019

5' UTR mutations in prostate cancer

Ecancer, April 15, 2019

At the American Association for Cancer Research annual meeting, Fred Hutch Dr. Yiting Lim explained the 5’ UTR mutations that are present among the DNA of prostate cancer patients.

ECancer
April 15, 2019

5' UTR mutations in prostate cancer

At the American Association for Cancer Research annual meeting, Fred Hutch Dr. Yiting Lim explained the 5’ UTR mutations that are present among the DNA of prostate cancer patients.

ECancer
April 15, 2019

The disturbing links between too much weight and several types of cancer

Fred Hutch Dr. Jonathan Wright provided expert commentary on the relationship between excess weight and cancer risk. Dr. Wright is currently conducting a trial on overweight patients with low-grade, slow growing prostate cancer to see if monitoring their glucose levels through a weight loss period will improve their cancer outcomes.

The Washington Post
April 14, 2019

The disturbing links between too much weight and several types of cancer

Fred Hutch Dr. Jonathan Wright provided expert commentary on the relationship between excess weight and cancer risk. 

The Washington Post
April 14, 2019

A's Stephen Piscotty, Giants' Buster Posey nominated for Hutch Award

NBC Sports Bay Area profiled the nominees for the 54th annual Hutch Awards and how the honor represents the legacy of Fred Hutchinson.

NBC Sports Bay Area
April 09, 2019

A's Stephen Piscotty, Giants' Buster Posey nominated for Hutch Award

NBC Sports Bay Area profiled the nominees for the 54th annual Hutch Awards and how the honor represents the legacy of Fred Hutchinson.

NBC Sports Bay Area
April 09, 2019

Q&A: Epigenetic therapies for breast cancer

In this Q&A, Dr. Nancy E. Davidson, director of Fred Hutch’s Clinical Research Division and executive director and president of Seattle Cancer Care Alliance, discussed the latest breast cancer research and what has been learned so far in clinical trials for epigenetic therapies.

The Scientist
April 04, 2019

Q&A: Epigenetic therapies for breast cancer

In this Q&A, Dr. Nancy E. Davidson, director of Fred Hutch’s Clinical Research Division and executive director and president of Seattle Cancer Care Alliance, discussed the latest breast cancer research and what has been learned so far in clinical trials for epigenetic therapies.

The Scientist
April 04, 2019

Working Geek: Fred Hutch CIO Kathy Alexion shifts from ‘corporate soldier’ to mission driven

Fred Hutch CIO Kathy Alexion is profiled in this feature piece as GeekWire’s ‘Working Geek’.

GeekWire
March 15, 2019

Working Geek: Fred Hutch CIO Kathy Alexion shifts from ‘corporate soldier’ to mission driven

Fred Hutch CIO Kathy Alexion is profiled in this feature piece as GeekWire’s ‘Working Geek’.

GeekWire
March 15, 2019

Seattle Mayor Jenny Durkan promotes cancer research amid personal battle

KING 5 documented Seattle Mayor Jenny Durkan’s visit to Fred Hutch to discuss the future of cancer research in Seattle. 

King 5
March 13, 2019

Seattle’s only community lab puts a DIY spin on biotech

Regina Wu, who works in Fred Hutch’s Science Education Partnership program, is featured for her efforts in co-founding Seattle’s only community science lab.

Crosscut
March 13, 2019

Seattle Mayor Jenny Durkan promotes cancer research amid personal battle

KING 5 documented Seattle Mayor Jenny Durkan’s visit to Fred Hutch to discuss the future of cancer research in Seattle. 

King 5
March 13, 2019

Seattle’s only community lab puts a DIY spin on biotech

Regina Wu, who works in Fred Hutch’s Science Education Partnership program, is featured for her efforts in co-founding Seattle’s only community science lab.

Crosscut
March 13, 2019

Oral blood thinner may reduce blood clots in high-risk patients with cancer

CURE profiled Dr. Gary Lyman and a New England Journal of Medicine study he co-authored that evaluated a drug’s safety and efficacy in preventing blood clots in cancer patients. The results from this study, known as the CASSINI trial, showed that the drug may reduce the risk of blood clots in cancer patients.

Cure
March 08, 2019

Oral blood thinner may reduce blood clots in high-risk patients with cancer

CURE profiled Dr. Gary Lyman and a New England Journal of Medicine study he co-authored that evaluated a drug’s safety and efficacy in preventing blood clots in cancer patients. The results from this study, known as the CASSINI trial, showed that the drug may reduce the risk of blood clots in cancer patients.

Cure
March 08, 2019

An antibody-inspired small molecule could make for a better flu treatment

Fred Hutch’s Dr. Jesse Bloom commented on a study evaluating the early development of a new antiviral drug for influenza. He said, “We need more drugs in the fight against flu, and this approach could provide them."

NPR
March 07, 2019

An antibody-inspired small molecule could make for a better flu treatment

Fred Hutch’s Dr. Jesse Bloom commented on a study evaluating the early development of a new antiviral drug for influenza. He said, “We need more drugs in the fight against flu, and this approach could provide them."

NPR
March 07, 2019

Diversity in Science

Vishavjit Singh, a political cartoonist, performance artist and activist visited Fred Hutch to discuss how to confront biases and celebrate diversity and inclusion. This piece highlights his visit and the efforts at Fred Hutch to foster a supportive and inclusive scientific community. 

King 5
March 05, 2019

Second HIV patient may be cured after treatment

Dr. Hans-Peter Kiem, co-director of Fred Hutch’s HIV cure research program, provided insight around the second person who reportedly has been cured of HIV. 

HealthDay
March 05, 2019

London man seems to be free of HIV in second such case

Fred Hutch virologist Dr. Keith Jerome provided expert commentary about the second person who reportedly has been cured of HIV.

Associated Press
March 05, 2019

Diversity in Science

Vishavjit Singh, a political cartoonist, performance artist and activist visited Fred Hutch to discuss how to confront biases and celebrate diversity and inclusion. This piece highlights his visit and the efforts at Fred Hutch to foster a supportive and inclusive scientific community. 

King 5
March 05, 2019

Second HIV patient may be cured after treatment

Dr. Hans-Peter Kiem, co-director of Fred Hutch’s HIV cure research program, provided insight around the second person who reportedly has been cured of HIV. 

HealthDay
March 05, 2019

London man seems to be free of HIV in second such case

Fred Hutch virologist Dr. Keith Jerome provided expert commentary about the second person who reportedly has been cured of HIV.

Associated Press
March 05, 2019

Tobacco 21 and cancer consequences

KING 5 aired multiple stories on Dr. Jonathan Bricker’s efforts to help cancer patients quit smoking and to support the Washington state tobacco 21 bill which will raise the age of smoking from 18 to 21. The bill was signed into law at Fred Hutch on April 5th.

King 5
March 04, 2019

Ten years after the ‘Berlin patient,’ doctors announce a second person has been effectively ‘cured’ of HIV

Fred Hutch virologist Dr. Keith Jerome provided context around news of the second person who reportedly has been cured of HIV. He commented, “Now there’s not one, but two people that others living with HIV can look toward for encouragement.”

STAT
March 04, 2019

Tobacco 21 and cancer consequences

KING 5 aired multiple stories on Dr. Jonathan Bricker’s efforts to help cancer patients quit smoking and to support the Washington state tobacco 21 bill which will raise the age of smoking from 18 to 21. The bill was signed into law at Fred Hutch on April 5th.

King 5
March 04, 2019

Ten years after the ‘Berlin patient,’ doctors announce a second person has been effectively ‘cured’ of HIV

Fred Hutch virologist Dr. Keith Jerome provided context around news of the second person who reportedly has been cured of HIV. He commented, “Now there’s not one, but two people that others living with HIV can look toward for encouragement.”

STAT
March 04, 2019

From LA's 'Jungle' to the forefront of cancer research in Seattle

In this profile piece, Eric Nealy, a graduate research assistant in Dr. Jim Olson’s lab, discusses how with the help of his mom, his high school biology teacher, and the only African American science professor he could find at college helped him pursue a career in cancer research.

Crosscut
February 26, 2019

Hutchinson Institute for Cancer Outcomes Research names co-director

Dr. Veena Shankaran is profiled about her new role as the co-director of Hutchinson Institute for Cancer Outcomes Research. 

HemOnc Today
February 26, 2019

From LA's 'Jungle' to the forefront of cancer research in Seattle

In this profile piece, Eric Nealy, a graduate research assistant in Dr. Jim Olson’s lab, discusses how with the help of his mom, his high school biology teacher, and the only African American science professor he could find at college helped him pursue a career in cancer research.

Crosscut
February 26, 2019

Hutchinson Institute for Cancer Outcomes Research names co-director

Dr. Veena Shankaran is profiled about her new role as the co-director of Hutchinson Institute for Cancer Outcomes Research. 

HemOnc Today
February 26, 2019

Many newly diagnosed Patients with Cancer Are Unaware of Hepatitis Infection

This article features a recent study by Fred Hutch researcher Dr. Scott Ramsey published in JAMA Oncology which found that many cancer patients were had undiagnosed Hepatitis B and C and HIV infection.

CURE
February 25, 2019

Many newly diagnosed Patients with Cancer Are Unaware of Hepatitis Infection

This article features a recent study by Fred Hutch researcher Dr. Scott Ramsey published in JAMA Oncology which found that many cancer patients were had undiagnosed Hepatitis B and C and HIV infection.

CURE
February 25, 2019

Adding ibrutinib to CAR T-Cell therapy increases response rates in CLL

Dr. Jordan Gauthier explains his findings on a combination immunotherapy treatment. Gauthier and his team found that adding the targeted therapy drug ibrutinib to CAR T-cell therapy led to improved responses in patients with relapsed/refractory chronic lymphocytic leukemia.

Targeted Oncology,
February 22, 2019

Adding ibrutinib to CAR T-Cell therapy increases response rates in CLL

Dr. Jordan Gauthier explains his findings on a combination immunotherapy treatment. Gauthier and his team found that adding the targeted therapy drug ibrutinib to CAR T-cell therapy led to improved responses in patients with relapsed/refractory chronic lymphocytic leukemia.

Targeted Oncology,
February 22, 2019

Rivaroxaban decreases VTE incidence during intervention period among patients with cancer

This article features Dr. Gary Lyman’s recent research published in the New England Journal of Medicine. This was the first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk.

Healio
February 21, 2019

Rivaroxaban decreases VTE incidence during intervention period among patients with cancer

This article features Dr. Gary Lyman’s recent research published in the New England Journal of Medicine. This was the first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk.

Healio
February 21, 2019

Dormant tumor cells can be sensitized to chemotherapy

This blog post features Dr. Cyrus Ghajar’s latest work on metastatic breast cancer showing that dormant tumor cells can be sensitized to chemotherapy. 

National Cancer Institute
February 20, 2019

Dormant tumor cells can be sensitized to chemotherapy

This blog post features Dr. Cyrus Ghajar’s latest work on metastatic breast cancer showing that dormant tumor cells can be sensitized to chemotherapy. 

National Cancer Institute
February 20, 2019

Vaccines don’t work against some viruses. CRISPR might one day fix that

This article notes research led by Dr. Justin Taylor using CRISPR, a gene-editing tool, to fight viruses when vaccines can’t. Taylor explained how his team has been investigating CRISPR as a tool to edit B cells in mice that could synthesize antibodies against respiratory syncytial virus (RSV). 

STAT
February 19, 2019

Why do only eight percent of cancer patients in the U.S. participate in clinical trials?

This article features Dr. Joe Unger’s recent study on barriers to clinical trials. Unger’s study showed that structural and clinical barriers prevent more than 3 out of 4 cancer patients from participating in clinical trials.

Forbes
February 19, 2019

Next steps for CAR T cells in B-cell lymphomas

Dr. Victor Chow explains different treatment settings that CAR T-cell therapy is used in patients with B-cell lymphomas. He states that, “While CAR T cells have been approved for treatment of individuals after two or more lines of therapy, studies are now looking at moving this to the upfront setting.”

Targeted Oncology
February 19, 2019

Vaccines don’t work against some viruses. CRISPR might one day fix that

This article notes research led by Dr. Justin Taylor using CRISPR, a gene-editing tool, to fight viruses when vaccines can’t. Taylor explained how his team has been investigating CRISPR as a tool to edit B cells in mice that could synthesize antibodies against respiratory syncytial virus (RSV). 

STAT
February 19, 2019

Why do only eight percent of cancer patients in the U.S. participate in clinical trials?

This article features Dr. Joe Unger’s recent study on barriers to clinical trials. Unger’s study showed that structural and clinical barriers prevent more than 3 out of 4 cancer patients from participating in clinical trials.

Forbes
February 19, 2019

Next steps for CAR T cells in B-cell lymphomas

Dr. Victor Chow explains different treatment settings that CAR T-cell therapy is used in patients with B-cell lymphomas. He states that, “While CAR T cells have been approved for treatment of individuals after two or more lines of therapy, studies are now looking at moving this to the upfront setting.”

Targeted Oncology
February 19, 2019

Uncovering the enemy within

This article on new techniques to detect minimal residual disease includes expert commentary by Dr. Mary-Percival and highlights trials that are going on at Fred Hutch to examine personalized cell therapies for treating MRD in different blood cancers. 

CURE
February 13, 2019

Uncovering the enemy within

This article on new techniques to detect minimal residual disease includes expert commentary by Dr. Mary-Percival and highlights trials that are going on at Fred Hutch to examine personalized cell therapies for treating MRD in different blood cancers. 

CURE
February 13, 2019

Why gene editing may hold the promise of a herpes cure

Dr. Keith Jerome is featured in a story of research progress in treating herpes. He explains how his work with the gene editing tool – a class of enzymes called meganucleases – is showing more success in getting rid of the virus. 

Men’s Health
February 12, 2019

Why gene editing may hold the promise of a herpes cure

Dr. Keith Jerome is featured in a story of research progress in treating herpes. He explains how his work with the gene editing tool – a class of enzymes called meganucleases – is showing more success in getting rid of the virus. 

Men’s Health
February 12, 2019

Expert shares treatment options for localized muscle-invasive bladder cancer

Dr. Jonathan Wright discusses the available therapies for patients with localized muscle-invasive bladder cancer which include neoadjuvant chemotherapy, upfront cystectomy and immunotherapy. 

Targeted Oncology
February 11, 2019

Expert shares treatment options for localized muscle-invasive bladder cancer

Dr. Jonathan Wright discusses the available therapies for patients with localized muscle-invasive bladder cancer which include neoadjuvant chemotherapy, upfront cystectomy and immunotherapy. 

Targeted Oncology
February 11, 2019

Microsoft Healthcare reveals more of its strategy with new cloud and AI products for hospitals

GeekWire mentioned Fred Hutch’s work with Microsoft on helping cancer patients better track their treatment side effects.

GeekWire
February 07, 2019

Microsoft Healthcare reveals more of its strategy with new cloud and AI products for hospitals

GeekWire mentioned Fred Hutch’s work with Microsoft on helping cancer patients better track their treatment side effects.

GeekWire
February 07, 2019

An atlas of HIV’s ‘escape routes’ could improve vaccine design

This article features recent HIV research from Fred Hutch Drs. Jesse Bloom and Julie Overbaugh. Researchers have created an atlas of immune-evading mutations HIV mutations, providing insight on the functional interactions between antibodies and HIV. 

FierceBiotech
February 04, 2019

Tech moves: Dave Parker leaves Seven Peaks Ventures; Fred Hutch names a new CIO; and more

Kathy Alexion’s new role as Fred Hutch’s CIO was announced in GeekWire’s weekly tech moves column. Alexion previously supported former CIO Matthew Trunnell since 2016. 

GeekWire
February 04, 2019

Obesity triggering rising cancer rates in millennials

Fred Hutch researcher Stephen Schwartz provides expert commentary on a study published in The Lancet Public Health on obesity and cancer. 

Everyday Health
February 04, 2019

An atlas of HIV’s ‘escape routes’ could improve vaccine design

This article features recent HIV research from Fred Hutch Drs. Jesse Bloom and Julie Overbaugh. Researchers have created an atlas of immune-evading mutations HIV mutations, providing insight on the functional interactions between antibodies and HIV. 

FierceBiotech
February 04, 2019

Tech moves: Dave Parker leaves Seven Peaks Ventures; Fred Hutch names a new CIO; and more

Kathy Alexion’s new role as Fred Hutch’s CIO was announced in GeekWire’s weekly tech moves column. Alexion previously supported former CIO Matthew Trunnell since 2016. 

GeekWire
February 04, 2019

Obesity triggering rising cancer rates in millennials

Fred Hutch researcher  Dr. Stephen Schwartz provides expert commentary on a study published in The Lancet Public Health on obesity and cancer. 

Everyday Health
February 04, 2019

Five benefits of being an early riser

This article features research led by Fred Hutch researcher Dr. Anne McTiernan showing that women who exercised for 45 minutes in the morning 5 days a week reported 70 percent better sleep than before the study. 

The Guardian
February 03, 2019

Five benefits of being an early riser

This article features research led by Fred Hutch researcher Dr. Anne McTiernan showing that women who exercised for 45 minutes in the morning 5 days a week reported 70 percent better sleep than before the study. 

The Guardian
February 03, 2019

Tech moves: Rhapsody adds CCO as ‘Powered by Napster’ formally launches; DreamBox hires CFO following cash infusion; and more

Dr. Veena Shankaran’s new role as the co-director of Fred Hutch’s healthcare economics and policy group was announced in GeekWire’s weekly tech moves column. 

GeekWire
January 31, 2019

1st of its kind Seattle flu study aims to stop flu before it becomes pandemic

Fred Hutch Dr. Trevor Bedford comments on the value of the Seattle Flu Study.

KIRO
January 31, 2019

Tech moves: Rhapsody adds CCO as ‘Powered by Napster’ formally launches; DreamBox hires CFO following cash infusion; and more

Dr. Veena Shankaran’s new role as the co-director of Fred Hutch’s healthcare economics and policy group was announced in GeekWire’s weekly tech moves column. 

GeekWire
January 31, 2019

1st of its kind Seattle flu study aims to stop flu before it becomes pandemic

Fred Hutch Dr. Trevor Bedford comments on the value of the Seattle Flu Study.

KIRO
January 31, 2019

Seattle’s HIV Hope

Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research. 

Cascadia Magazine
January 30, 2019

Seattle’s HIV Hope

Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research. 

Cascadia Magazine
January 30, 2019

Healthy Living: Daily dose of exercise key woman living with stage 4 cancer

Fred Hutch researcher Dr. Anne McTiernan provided expert commentary on the value of exercise for those who have breast cancer. 

Q13 Fox
January 29, 2019

Healthy Living: Moderate exercise can reduce breast cancer risk 20%, research finds

Fred Hutch researcher Dr. Anne McTiernan is featured in this segment for her research on exercise in relation to breast cancer prevention. Dr. McTiernan found that moderate exercise, 45 minutes a day, 5 days a week, can reduce breast cancer risk by as much as 20%. 

Q13 Fox
January 29, 2019

Healthy Living: Daily dose of exercise key woman living with stage 4 cancer

Fred Hutch researcher Dr. Anne McTiernan provided expert commentary on the value of exercise for those who have breast cancer. 

Q13 Fox
January 29, 2019

Healthy Living: Moderate exercise can reduce breast cancer risk 20%, research finds

Fred Hutch researcher Dr. Anne McTiernan is featured in this segment for her research on exercise in relation to breast cancer prevention. Dr. McTiernan found that moderate exercise, 45 minutes a day, 5 days a week, can reduce breast cancer risk by as much as 20%. 

Q13 Fox
January 29, 2019

Information, not urgency, boosts parents’ confidence in HPV vaccine

This article features Fred Hutch researcher Dr. Parth Shah’s latest research on HPV vaccination. Dr. Shah found that parents were more confident in HPV vaccination and more motivated to have their child vaccinated by being exposed to physician messages that provided information rather than a sense of urgency. 

Reuters Health – MD Linx
January 28, 2019

Information, not urgency, boosts parents’ confidence in HPV vaccine

This article features Fred Hutch researcher Dr. Parth Shah’s latest research on HPV vaccination. Dr. Shah found that parents were more confident in HPV vaccination and more motivated to have their child vaccinated by being exposed to physician messages that provided information rather than a sense of urgency. 

Reuters Health – MD Linx
January 28, 2019

A Conversation with Gary Lyman, MD: Biosimilars and the Search for the Cure To Cancer Treatment’s Financial Toxicity

Fred Hutch researcher Dr. Gary Lyman is featured in this Q&A piece on biosimilars. Dr. Lyman provides comments about how the high prices of cancer treatment contribute to financial toxicity

Managed Care Online
January 25, 2019

Undiagnosed hepatitis common among people with cancer

This article highlights a recent study which found a high rate of undiagnosed acute and chronic hepatitis among cancer patients. Fred Hutch researcher Dr. Scott Ramsey provides expert commentary on the implications the study has in terms of screening. U.S. News & World Report also covered this study. 

POZ
January 25, 2019

A Conversation with Gary Lyman, MD: Biosimilars and the Search for the Cure To Cancer Treatment’s Financial Toxicity

Fred Hutch researcher Dr. Gary Lyman is featured in this Q&A piece on biosimilars. Dr. Lyman provides comments about how the high prices of cancer treatment contribute to financial toxicity

Managed Care Online
January 25, 2019

Undiagnosed hepatitis common among people with cancer

This article highlights a recent study which found a high rate of undiagnosed acute and chronic hepatitis among cancer patients. Fred Hutch researcher Dr. Scott Ramsey provides expert commentary on the implications the study has in terms of screening. U.S. News & World Report also covered this study. 

POZ
January 25, 2019

Got the flu? Seattle wants to swab your nose for a massive health data project

This story features the Seattle Flu Study, a new project from the Brotman Baty Institute which was co-founded by Seattle Children’s, UW Med and Fred Hutch. The study will look at 10,000 swabs to better understand how the flu spreads and how to prevent it. Fred Hutch’s Dr. Trevor Bedford is the lead data scientist for the study. 

GeekWire
January 23, 2019

What to eat – and how to feel better – during menopause

This article includes a mention of a Fred Hutch study led by Dr. Marian Neuhouser which found that women diagnosed with breast cancer who ate a low-fat diet were more likely to survive. 

The Seattle Times
January 23, 2019

Got the flu? Seattle wants to swab your nose for a massive health data project

This story features the Seattle Flu Study, a new project from the Brotman Baty Institute which was co-founded by Seattle Children’s, UW Med and Fred Hutch. The study will look at 10,000 swabs to better understand how the flu spreads and how to prevent it. Fred Hutch’s Dr. Trevor Bedford is the lead data scientist for the study. 

GeekWire
January 23, 2019

What to eat – and how to feel better – during menopause

This article includes a mention of a Fred Hutch study led by Dr. Marian Neuhouser which found that women diagnosed with breast cancer who ate a low-fat diet were more likely to survive. 

The Seattle Times
January 23, 2019

Scientists discover new potential way to stop breast cancer from spreading

Dr. Cyrus Ghajar’s latest research on metastatic breast cancer is the focus of this piece. Dr. Ghajar’s work details how to kill dormant breast cancer cells in their sleep. Several other outlets including GeekWire, KOMO-TV and FireceBiotech also covered this news.

Forbes
January 21, 2019

Scientists discover new potential way to stop breast cancer from spreading

Dr. Cyrus Ghajar’s latest research on metastatic breast cancer is the focus of this piece. Dr. Ghajar’s work details how to kill dormant breast cancer cells in their sleep. Several other outlets including GeekWire, KOMO-TV and FireceBiotech also covered this news.

Forbes
January 21, 2019

Lung transplant patients face elevated lung cancer risk

Fred Hutch Dr. Matthew Triplette’s recent research on lung cancer is featured in this piece. Dr. Triplette and his team showed that lung cancer risk was increased after lung transplantation, especially in the non-transplanted lung of single lung transplant recipients.

Ecancer
January 19, 2019

Lung transplant patients face elevated lung cancer risk

Fred Hutch Dr. Matthew Triplette’s recent research on lung cancer is featured in this piece. Dr. Triplette and his team showed that lung cancer risk was increased after lung transplantation, especially in the non-transplanted lung of single lung transplant recipients.

Ecancer
January 19, 2019

Medical ‘breakthrough’ may spell end of potentially toxic drugs in transplant recipients ABC News (Australia), Jan. 17, 2019

Dr. Geoffrey Hill and collaborators in Australia discovered how a common virus called cytomegalovirus reactivates in transplantation patients. In a study published in Science, the researchers found that strain-specific antibodies made from B cells are responsible for keeping CMV suppressed in mice, without the need for any other immune cells. 

ABC News
January 17, 2019

Medical ‘breakthrough’ may spell end of potentially toxic drugs in transplant recipients ABC News (Australia), Jan. 17, 2019

Dr. Geoffrey Hill and collaborators in Australia discovered how a common virus called cytomegalovirus reactivates in transplantation patients. In a study published in Science, the researchers found that strain-specific antibodies made from B cells are responsible for keeping CMV suppressed in mice, without the need for any other immune cells. 

ABC News
January 17, 2019

Comorbidities associated with lower clinical trial participation

This article features Dr. Joseph Unger’s recent study in JAMA Oncology on clinical trial participation. Dr. Unger shows that patients with comorbidities are less likely to participate in clinical trials.

CURE Today
January 16, 2019

Comorbidities associated with lower clinical trial participation

This article features Dr. Joseph Unger’s recent study in JAMA Oncology on clinical trial participation. Dr. Unger shows that patients with comorbidities are less likely to participate in clinical trials.

CURE Today
January 16, 2019

5 ways to protect your prostate

This piece highlights a study published in JNCI by Fred Hutch Dr. Joseph Unger, which shows that men who’ve taken 5-alpha reductase inhibitors had a 21 percent reduced risk of PCa 16 years later. 

Men’s Health
January 14, 2019

5 ways to protect your prostate

This piece highlights a study published in JNCI by Fred Hutch Dr. Joseph Unger, which shows that men who’ve taken 5-alpha reductase inhibitors had a 21 percent reduced risk of PCa 16 years later. 

Men’s Health
January 14, 2019

Geek of the Week: Fred Hutch’s Steve Pergam caught a ’bug’ for infectious diseases and research

Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch. 
 

GeekWire
January 11, 2019

Cancer comorbidities reduce clinical trial participation, new SWOG study shows

Fred Hutch researcher Dr. Joseph Unger’s latest research on clinical trial participation is featured in this piece. Dr. Unger and his team showed that cancer patients with other illnesses or conditions, are less likely to be offered to join a clinical trial, and therefore less likely to enroll. This research was published in several other outlets including Healio, Medical Health News and MedPage Today. 

ecancer
January 11, 2019

Cancer comorbidities reduce clinical trial enrollment, study finds

This piece features Fred Hutch Dr. Joseph Unger’s latest research showing that expanding clinical trial eligibility criteria to allow patients with comorbidities would give opportunities for up to 6,317 cancer patients to be allowed to join a trial every year. 

Becker’s Hospital Review
January 11, 2019

Geek of the Week: Fred Hutch’s Steve Pergam caught a ’bug’ for infectious diseases and research

Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch. 
 

GeekWire
January 11, 2019

Cancer comorbidities reduce clinical trial participation, new SWOG study shows

Fred Hutch researcher Dr. Joseph Unger’s latest research on clinical trial participation is featured in this piece. Dr. Unger and his team showed that cancer patients with other illnesses or conditions, are less likely to be offered to join a clinical trial, and therefore less likely to enroll. This research was published in several other outlets including Healio, Medical Health News and MedPage Today. 

ecancer
January 11, 2019

Cancer comorbidities reduce clinical trial enrollment, study finds

This piece features Fred Hutch Dr. Joseph Unger’s latest research showing that expanding clinical trial eligibility criteria to allow patients with comorbidities would give opportunities for up to 6,317 cancer patients to be allowed to join a trial every year. 

Becker’s Hospital Review
January 11, 2019

Cord blood transplantation provides ‘donor for every patient’

Fred Hutch Dr. Filippo Milano in featured in this Q&A piece about how cord blood is used for transplants. 

CURE Today
January 05, 2019

Cord blood transplantation provides ‘donor for every patient’

Fred Hutch Dr. Filippo Milano in featured in this Q&A piece about how cord blood is used for transplants. 

CURE Today
January 05, 2019

Fred Hutchinson bone barrow transplant program receives national recognition

Fred Hutch’s bone marrow transplant program at Seattle Cancer Care Alliance, the Hutch’s clinical care partner, received national recognition for its survival rates by the Center for International Blood and Marrow Transplant Research’s annual report.

Healio
December 29, 2018

Fred Hutchinson bone barrow transplant program receives national recognition

Fred Hutch’s bone marrow transplant program at Seattle Cancer Care Alliance, the Hutch’s clinical care partner, received national recognition for its survival rates by the Center for International Blood and Marrow Transplant Research’s annual report.

Healio
December 29, 2018

Knowledge of benefits, harms of medical marijuana for cancer ‘far from complete’

Fred Hutch researcher Dr. Steve Pergam comments on cannabis use among cancer patients.

Healio
December 25, 2018

Knowledge of benefits, harms of medical marijuana for cancer ‘far from complete’

Fred Hutch researcher Dr. Steve Pergam comments on cannabis use among cancer patients.

Healio
December 25, 2018

6 vitamin myths you have to stop believing – and 2 vitamins you actually do need

Fred Hutch Dr. Marian Neuhouser provides expert comments on the benefits of multivitamins.

MSN
December 22, 2018

6 vitamin myths you have to stop believing – and 2 vitamins you actually do need

Fred Hutch Dr. Marian Neuhouser provides expert comments on the benefits of multivitamins.

MSN
December 22, 2018

The Allen Institute for Immunology

Dr. Gary Gilliland, Fred Hutch president and director, comments on the newly-announced Allen Institute for Immunology, which includes a research collaboration with Fred Hutch.

KING 5
December 13, 2018

The Allen Institute for Immunology

Dr. Gary Gilliland, Fred Hutch president and director, comments on the newly-announced Allen Institute for Immunology, which includes a research collaboration with Fred Hutch.

KING 5
December 13, 2018

Excess body weight responsible for 4% of cancers worldwide, study says

Fred Hutch Dr. Anne McTiernan provides expert commentary on a new study that found that excess body weight is responsible for 4% of cancer globally.

CNN
December 12, 2018

Biotech journalist Luke Timmerman sets his sights on Mount Kilimanjaro and $1M for cancer research

This article features Luke Timmerman, a local biotech journalist who is climbing Mount Kilimanjaro in July as a part of the Climb to Fight Cancer to raise money for Fred Hutch. After climbing Mount Everest in 2018, Timmerman raised $340,000 for cancer research. Timmerman now hopes to raise $850,00 with this climb.

GeekWire
December 12, 2018

Excess body weight responsible for 4% of cancers worldwide, study says

Fred Hutch Dr. Anne McTiernan provides expert commentary on a new study that found that excess body weight is responsible for 4% of cancer globally.

CNN
December 12, 2018

Biotech journalist Luke Timmerman sets his sights on Mount Kilimanjaro and $1M for cancer research

This article features Luke Timmerman, a local biotech journalist who is climbing Mount Kilimanjaro in July as a part of the Climb to Fight Cancer to raise money for Fred Hutch. After climbing Mount Everest in 2018, Timmerman raised $340,000 for cancer research. Timmerman now hopes to raise $850,00 with this climb.

GeekWire
December 12, 2018

Robust future ahead for stem cell transplants

Fred Hutch’s Dr. Geoffrey Hill provides expert commentary on stem cell transplantation in relation to CAR Ts.

OncLive
December 06, 2018

Robust future ahead for stem cell transplants

Fred Hutch’s Dr. Geoffrey Hill provides expert commentary on stem cell transplantation in relation to CAR Ts.

OncLive
December 06, 2018

Seattle-area health care chiefs debate cancer treatment costs and innovations

Fred Hutch Dr. Jim Olson provides expert commentary on the field of cancer care and research as a Seattle-area health care leader at a PSBJ health care event held earlier this month. Olson’s “tumor paint” technology is highlighted as a leading technology in the field of cancer care.

Puget Sound Business Journal
December 05, 2018

Amazon push into health data analytics inspires awe – and skepticism

This article highlights Fred Hutch’s work with Amazon on AWS’ Comprehend Medical Service. Matthew Trunnell provides expert commentary on the benefits of the service.

Politico
December 05, 2018

Seattle-area health care chiefs debate cancer treatment costs and innovations

Fred Hutch Dr. Jim Olson provides expert commentary on the field of cancer care and research as a Seattle-area health care leader at a PSBJ health care event held earlier this month. Olson’s “tumor paint” technology is highlighted as a leading technology in the field of cancer care.

Puget Sound Business Journal
December 05, 2018

Amazon push into health data analytics inspires awe – and skepticism

This article highlights Fred Hutch’s work with Amazon on AWS’ Comprehend Medical Service. Matthew Trunnell provides expert commentary on the benefits of the service.

Politico
December 05, 2018

CAR-T Cell Therapy combination shows promise in relapsed/refractor leukemia

This article features Fred Hutch Dr. Jordan Gauthier’s study findings presented at the 2018 ASH conference. His study shows that using chimeric antigen receptor (CAR)-T cell therapy plus Imbruvica, a targeted treatment, could improve outcomes in patients with relapsed or refractory chronic lymphocytic leukemia. Gauthier participated in an ASH press briefing and his work was covered by numerous other outlets including OncLive, Medpage Today, HemOnc Today, Targeted Oncology, and the Video Journal of Hematological Oncology.

CURE
December 04, 2018

CAR-T Cell Therapy combination shows promise in relapsed/refractor leukemia

This article features Fred Hutch Dr. Jordan Gauthier’s study findings presented at the 2018 ASH conference. His study shows that using chimeric antigen receptor (CAR)-T cell therapy plus Imbruvica, a targeted treatment, could improve outcomes in patients with relapsed or refractory chronic lymphocytic leukemia. Gauthier participated in an ASH press briefing and his work was covered by numerous other outlets including OncLive, Medpage Today, HemOnc Today, Targeted Oncology, and the Video Journal of Hematological Oncology.

CURE
December 04, 2018

Fred Hutch gala raises $10.4 million for cancer research, including $4 million from Microsoft

Fred Hutch’s 2018 annual holiday gala is featured for raising $10.4 million for cancer research.

Puget Sound Business Journal
December 03, 2018

Study identifies 40 new genetic variants associated with colorectal cancer risk

This article features the most comprehensive genome-wide association study of colorectal cancer risk to date, led by Dr. Ulrike “Riki” Peters. Peters and her team have discovered 40 new genetic variants associated with colorectal cancer risk.

Everyday Health
December 03, 2018

Fred Hutch gala raises $10.4 million for cancer research, including $4 million from Microsoft

Fred Hutch’s 2018 annual holiday gala is featured for raising $10.4 million for cancer research.

Puget Sound Business Journal
December 03, 2018

Study identifies 40 new genetic variants associated with colorectal cancer risk

This article features the most comprehensive genome-wide association study of colorectal cancer risk to date, led by Dr. Ulrike “Riki” Peters. Peters and her team have discovered 40 new genetic variants associated with colorectal cancer risk.

Everyday Health
December 03, 2018

Why should you care about Amazon’s new medical language processing service

Fred Hutch CIO Matthew Trunnell is quoted about how Fred Hutch is using Amazon’s new Comprehend Medical service.

Forbes
November 30, 2018

World AIDS Day

This segment, which aired on the eve of World AIDS Day, covers local and global HIV vaccine trials led by Fred Hutch. It includes interviews with Drs. Janine Maenza, Larry Corey and an HIV study vaccine participant.

KING 5
November 30, 2018

Amazon launches patient data-mining service to assist docs

This story details how Fred Hutch plans to utilize Amazon Comprehend Medical’s natural language processing capabilities and the benefits of doing so.

Computerworld
November 30, 2018

Why should you care about Amazon’s new medical language processing service

Fred Hutch CIO Matthew Trunnell is quoted about how Fred Hutch is using Amazon’s new Comprehend Medical service.

Forbes
November 30, 2018

World AIDS Day

This segment, which aired on the eve of World AIDS Day, covers local and global HIV vaccine trials led by Fred Hutch. It includes interviews with Drs. Janine Maenza, Larry Corey and an HIV study vaccine participant.

KING 5
November 30, 2018

Amazon launches patient data-mining service to assist docs

This story details how Fred Hutch plans to utilize Amazon Comprehend Medical’s natural language processing capabilities and the benefits of doing so.

Computerworld
November 30, 2018

Big tech expands footprint in health

This article mentions Fred Hutch's collaboration with Amazon Web Services on the new Comprehend Medical natural language processing service. Subscription required

The Wall Street Journal
November 27, 2018

Amazon unveils new service to mine and decode media records using artificial intelligence

Fred Hutch CIO Matthew Trunnell is quoted about how Fred Hutch is using Amazon’s new Comprehend Medical service.

GeekWire
November 27, 2018

Big tech expands footprint in health

This article mentions Fred Hutch's collaboration with Amazon Web Services on the new Comprehend Medical natural language processing service. Subscription required

The Wall Street Journal
November 27, 2018

Amazon unveils new service to mine and decode media records using artificial intelligence

Fred Hutch CIO Matthew Trunnell is quoted about how Fred Hutch is using Amazon’s new Comprehend Medical service.

GeekWire
November 27, 2018

Coping with head and neck cancer

Salene Jones, an assistant member in the Public Health Sciences Division at Fred Hutch, provides comments on depression screening for cancer patients in relation to a recent study that adds new information about suicide risk in head and neck cancer patients and survivors.

Cancer Today
November 21, 2018

Coping with head and neck cancer

Salene Jones, an assistant member in the Public Health Sciences Division at Fred Hutch, provides comments on depression screening for cancer patients in relation to a recent study that adds new information about suicide risk in head and neck cancer patients and survivors.

Cancer Today
November 21, 2018

Majority of HIV persistence during ART due to infected cell proliferation

This article features a recent study by Fred Hutch Drs. Dan Reeves and Josh Schiffer that shows that a majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originate from cellular proliferation, not viral replication.

Drug Target Review
November 20, 2018

Majority of HIV persistence during ART due to infected cell proliferation

This article features a recent study by Fred Hutch Drs. Dan Reeves and Josh Schiffer that shows that a majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originate from cellular proliferation, not viral replication.

Drug Target Review
November 20, 2018

Solving lymphoma’s stem-cell problem

Drs. Mary Flowers and Stephanie Lee provide expert comments on GvHD.

Nature
November 14, 2018

Solving lymphoma’s stem-cell problem

Drs. Mary Flowers and Stephanie Lee provide expert comments on GvHD.

Nature
November 14, 2018

Forbes 30 under 30: Healthcare

Alex Salter, a graduate student working in Stan Riddell's lab, made the Forbes 30 under 30 healthcare list for his work in immunotherapy.

Forbes
November 13, 2018

Forbes 30 under 30: Healthcare

Alex Salter, a graduate student working in Stan Riddell's lab, made the Forbes 30 under 30 healthcare list for his work in immunotherapy.

Forbes
November 13, 2018

It’s too early to take baby aspirin to cut ovarian cancer risk, but not too early to improve your diet

This article features research and comments by Dr. Marian Neuhouser on diet in relation to cancer prevention.

The Washington Post
November 12, 2018

It’s too early to take baby aspirin to cut ovarian cancer risk, but not too early to improve your diet

This article features research and comments by Dr. Marian Neuhouser on diet in relation to cancer prevention.

The Washington Post
November 12, 2018

How tech is unlocking a new way of thinking about health

Fred Hutch Dr. Elizabeth Krakow is featured in a recap of the personalized medicine panel at GeekWire's recent 2018 summit.

GeekWire
November 02, 2018

How tech is unlocking a new way of thinking about health

Fred Hutch Dr. Elizabeth Krakow is featured in a recap of the personalized medicine panel at GeekWire's recent 2018 summit.

GeekWire
November 02, 2018

Pricey precision medicine often financially toxic for cancer patients

Dr. Scott Ramsey and Dr. Gary Lyman provide expert comments on the cost of precision medicine and the impact it has on patients.

Kaiser Health News
November 01, 2018

Pricey precision medicine often financially toxic for cancer patients

Dr. Scott Ramsey and Dr. Gary Lyman provide expert comments on the cost of precision medicine and the impact it has on patients.

Kaiser Health News
November 01, 2018

Research finds 71 percent of tumors misidentified in children with rare cancer

This story summarizes a recent study by Dr. Jim Olson that shows 71 percent of tumors are misidentified in children with rare brain cancer due to limits in standard diagnostic methods.

KNKX-FM
October 25, 2018

Research finds 71 percent of tumors misidentified in children with rare cancer

This story summarizes a recent study by Dr. Jim Olson that shows 71 percent of tumors are misidentified in children with rare brain cancer due to limits in standard diagnostic methods.

KNKX-FM
October 25, 2018

Women Who Lead: Kelly O'Brien, mountaineer and philanthropy chief at Fred Hutch, aims high

This profile features Kelly O'Brien, vice president of philanthropy, in its Women Who Lead column that highlights “influential women leaders who are driving innovation and growth in the Puget Sound region."

Puget Sound Business Journal
October 19, 2018

Women Who Lead: Kelly O'Brien, mountaineer and philanthropy chief at Fred Hutch, aims high

This profile features Kelly O'Brien, vice president of philanthropy, in its Women Who Lead column that highlights “influential women leaders who are driving innovation and growth in the Puget Sound region."

Puget Sound Business Journal
October 19, 2018

The smaller the city, the bigger the flu epidemic

Dr. Trevor Bedford comments on a study that suggests that people living in smaller cities are more likely to face an intense outbreaks of seasonal flu during flu season.

Popular Science
October 18, 2018

The smaller the city, the bigger the flu epidemic

Dr. Trevor Bedford comments on a study that suggests that people living in smaller cities are more likely to face an intense outbreaks of seasonal flu during flu season.

Popular Science
October 18, 2018

Healthy Living: Doctors say exercise and diet can reduce risk of breast cancer

Dr. Anne McTiernan shares her top prevention tips during this breast cancer awareness month-focused interview.

KCPQ-TV
October 17, 2018

Healthy Living: Doctors say exercise and diet can reduce risk of breast cancer

Dr. Anne McTiernan shares her top prevention tips during this breast cancer awareness month-focused interview.

KCPQ-TV
October 17, 2018

The cancer that changed the course of Paul Allen’s life, and shaped his legacy

This story summarizes a recent study by Dr. Jim Olson that shows 71 percent of tumors are misidentified in children with rare brain cancer due to limits in standard diagnostic methods.

GeekWire
October 16, 2018

The cancer that changed the course of Paul Allen’s life, and shaped his legacy

This story summarizes a recent study by Dr. Jim Olson that shows 71 percent of tumors are misidentified in children with rare brain cancer due to limits in standard diagnostic methods.

GeekWire
October 16, 2018

Fred Hutch president on Non-Hodgkin’s Lymphoma

Our president and director Gary Gilliland, explains non-Hodgkin Lymphoma.

KING-TV
October 15, 2018

Fred Hutch president on Non-Hodgkin’s Lymphoma

Our president and director Gary Gilliland, explains non-Hodgkin Lymphoma.

KING-TV
October 15, 2018

Childhood abuse may increase the risk of endometriosis, study finds

This story featured a study led by Fred Hutch epidemiologist Holly Harris which shows that women who reported severe or chronic childhood abuse were 79% more likely to have endometriosis.

HealthCentral
October 11, 2018

Childhood abuse may increase the risk of endometriosis, study finds

This story featured a study led by Fred Hutch epidemiologist Holly Harris which shows that women who reported severe or chronic childhood abuse were 79% more likely to have endometriosis.

HealthCentral
October 11, 2018

Seattle scientists lead the way on HIV vaccine research

KOMO featured Kristen Cohen and Ro Yoon in a story about a new HIV vaccine trial for which Fred Hutch is one of two sites.

KOMO News
October 10, 2018

Seattle scientists lead the way on HIV vaccine research

KOMO featured Kristen Cohen and Ro Yoon in a story about a new HIV vaccine trial for which Fred Hutch is one of two sites.

KOMO News
October 10, 2018

New HIV vaccine study will test first-of-its-kind tech, with backing from the Gates Foundation

GeekWire covered the launch of a new HIV vaccine trial for which Fred Hutch will serve as one of two sites.

GeekWire
October 09, 2018

New HIV vaccine study will test first-of-its-kind tech, with backing from the Gates Foundation

GeekWire covered the launch of a new HIV vaccine trial for which Fred Hutch will serve as one of two sites.

GeekWire
October 09, 2018

Ongoing Efforts Seek to Refine, Expand CAR T-Cell Therapy

Fred Hutch’s Dr. Brian Till shared his expertise on new developments in CAR T cell therapy.

OncLive
October 08, 2018

Ongoing Efforts Seek to Refine, Expand CAR T-Cell Therapy

Fred Hutch’s Dr. Brian Till shared his expertise on new developments in CAR T cell therapy.

OncLive
October 08, 2018

Breast Cancer: Everything you should know to keep it out of your future

Dr. Jennifer Specht shared her insights in diagnosing, treating and preventing breast cancer.

Prevention
October 01, 2018

Breast Cancer: Everything you should know to keep it out of your future

Dr. Jennifer Specht shared her insights in diagnosing, treating and preventing breast cancer.

Prevention
October 01, 2018

How one Fort Collins girl gave hope to 86,000 people with blood cancers

Dr. Fred Applebaum, the Hutch’s executive vice president and deputy director, commented about the recipient of the first unrelated donor transplant, that eventually led to the national match registry.

Coloradoan
September 27, 2018

Hyundai grant to Fred Hutch to help childhood leukemia research

This story focused on a $300k grant Dr. Roland Walter received from Hyundai. It included interviews with Dr. Walter & a pediatric cancer patient.

KIRO-TV
September 27, 2018

Hyundai grant to Fred Hutch to help childhood leukemia research

This story focused on a $300k grant Dr. Roland Walter received from Hyundai. It included interviews with Dr. Walter & a pediatric cancer patient.

KIRO-TV
September 27, 2018

How one Fort Collins girl gave hope to 86,000 people with blood cancers

Dr. Fred Applebaum, the Hutch’s executive vice president and deputy director, commented about the recipient of the first unrelated donor transplant, that eventually led to the national match registry.

Coloradoan
September 27, 2018

Hyundai grant to Fred Hutch to help childhood leukemia research

This story focused on a $300k grant Dr. Roland Walter received from Hyundai. It included interviews with Dr. Walter & a pediatric cancer patient.

KIRO-TV
September 27, 2018

Hyundai grant to Fred Hutch to help childhood leukemia research

This story focused on a $300k grant Dr. Roland Walter received from Hyundai. It included interviews with Dr. Walter & a pediatric cancer patient.

KIRO-TV
September 27, 2018

Should we rely on artificial intelligence to provide advice about cancer?

Dr. Scott Ramsey, director of Fred Hutch’s health economics group, talked about a partnership between the Hutch and Microsoft, using artificial intelligence technology to help cancer patients detect early, subtle signs of complications in an effort to improve patient health while lowering costs.

U.S. News & World Report
September 26, 2018

Should we rely on artificial intelligence to provide advice about cancer?

Dr. Scott Ramsey, director of Fred Hutch’s health economics group, talked about a partnership between the Hutch and Microsoft, using artificial intelligence technology to help cancer patients detect early, subtle signs of complications in an effort to improve patient health while lowering costs.

U.S. News & World Report
September 26, 2018

Fred Hutch study discovers how cancer evades immunotherapies, sometimes returning years later

Fred Hutch researchers Drs. Aude Chapuis and Kelly Paulson were quoted about their study identifying a potential cause for relapse in patients treated with immunotherapy for Merkel cell carcinoma, a skin cancer.

GeekWire
September 24, 2018

Fred Hutch study discovers how cancer evades immunotherapies, sometimes returning years later

Fred Hutch researchers Drs. Aude Chapuis and Kelly Paulson were quoted about their study identifying a potential cause for relapse in patients treated with immunotherapy for Merkel cell carcinoma, a skin cancer.

GeekWire
September 24, 2018

The Roots of Rural Health Disparities

This story summarized a study led by Dr. Joe Unger focused on outcomes for rural vs. urban cancer patients.

Cancer Today
September 13, 2018

Do bacteria cause stomach cancer?

This article mentions research by Fred Hutch’s Dr. Nina Salama and her team that identified a strain of Helicobacter pylori associated with stomach cancer.

Medical News Today
September 13, 2018

The Roots of Rural Health Disparities

This story summarized a study led by Dr. Joe Unger focused on outcomes for rural vs. urban cancer patients.

Cancer Today
September 13, 2018

Do bacteria cause stomach cancer?

This article mentions research by Fred Hutch’s Dr. Nina Salama and her team that identified a strain of Helicobacter pylori associated with stomach cancer.

Medical News Today
September 13, 2018

Fred Hutchinson and Seattle’s baseball renaissance of 1938

This historical feature about Fred Hutchinson's baseball career includes comments from Dr. Fred Appelbaum on how naming the Center in Hutchinson's honor keeps it tied to the Seattle community and culture.

KIRO-FM
September 12, 2018

What’s the likelihood that CRISPR will cure cancer?

Dr. Hans-Peter Kiem, director of Fred Hutch’s stem cell and gene therapy program, is featured in this article about CRISPR, a new gene-editing tool.

U.S. News & World Report
September 12, 2018

Fred Hutchinson and Seattle’s baseball renaissance of 1938

This historical feature about Fred Hutchinson's baseball career includes comments from Dr. Fred Appelbaum on how naming the Center in Hutchinson's honor keeps it tied to the Seattle community and culture.

KIRO-FM
September 12, 2018

What’s the likelihood that CRISPR will cure cancer?

Dr. Hans-Peter Kiem, director of Fred Hutch’s stem cell and gene therapy program, is featured in this article about CRISPR, a new gene-editing tool.

U.S. News & World Report
September 12, 2018

How glioblastoma is treated

In this CNN story, Fred Hutch’s Dr. Eric Holland said studies using targeted cancer therapies against glioblastoma have been unexpectedly disappointing.

CNN
August 25, 2018

How glioblastoma is treated

In this CNN story, Fred Hutch’s Dr. Eric Holland said studies using targeted cancer therapies against glioblastoma have been unexpectedly disappointing.

CNN
August 25, 2018

Overlooked molecule might be key to how well cancer-fighting CAR-T cells work

Lead author Alex Salter and senior author Dr. Stanley Riddell were quoted in this STAT article about a Fred Hutch study on co-stimulatory domain, a component of chimeric antigen receptor (CAR) T cells. Different co-stimulatory domains might affect safety and efficacy of these immunotherapies.

STAT
August 21, 2018

Overlooked molecule might be key to how well cancer-fighting CAR-T cells work

Lead author Alex Salter and senior author Dr. Stanley Riddell were quoted in this STAT article about a Fred Hutch study on co-stimulatory domain, a component of chimeric antigen receptor (CAR) T cells. Different co-stimulatory domains might affect safety and efficacy of these immunotherapies.

STAT
August 21, 2018

Teens in Fred Hutch program aspire to be scientists, doctors

Fred Hutch's Science Education Partnership program was featured in this story, focusing on a new training program for high school sophomores and juniors

The Daily Herald (Everett, Washington)
August 15, 2018

Teens in Fred Hutch program aspire to be scientists, doctors

Fred Hutch's Science Education Partnership program was featured in this story, focusing on a new training program for high school sophomores and juniors

The Daily Herald (Everett, Washington)
August 15, 2018

Colon cancer screening guidelines may need revising

This story cites new research led by Fred Hutch focused on the ideal age for men and women to receive their first colonoscopy screening.

Scientific American
August 14, 2018

Colon cancer screening guidelines may need revising

This story cites new research led by Fred Hutch focused on the ideal age for men and women to receive their first colonoscopy screening.

Scientific American
August 14, 2018

Maple Valley mom among growing number of millennials with colon cancer

Lauren Nudo, a stage 4 colon cancer patient, is featured in this story about the importance of awareness and raising money for cancer research.

KING-TV
August 10, 2018

Woman learns to bike to honor late father at Fred Hutch’s Obliteride

KING-TV newscasts provided extensive coverage of Fred Hutch’s Obliteride biking/walking fundraising event, including numerous stories about participants and their inspiration and motivation. This story profiled Smeeta Hirani and how she learned to ride a bike to honor her father, who died from lung cancer.

KING-TV
August 10, 2018

Maple Valley mom among growing number of millennials with colon cancer

Lauren Nudo, a stage 4 colon cancer patient, is featured in this story about the importance of awareness and raising money for cancer research.

KING-TV
August 10, 2018

Woman learns to bike to honor late father at Fred Hutch’s Obliteride

KING-TV newscasts provided extensive coverage of Fred Hutch’s Obliteride biking/walking fundraising event, including numerous stories about participants and their inspiration and motivation. This story profiled Smeeta Hirani and how she learned to ride a bike to honor her father, who died from lung cancer.

KING-TV
August 10, 2018

How this cancer therapy went from scientific underdog to potential cure

This GeekWire article and podcast weaves together Fred Hutch expertise in bone marrow transplantation and newer cell therapies, such as CAR T. The Hutch’s Dr. Stan Riddell and Dr. David Maloney talk about how CAR T-cell immunotherapy and how it was considered a crazy idea in the 1980s.

GeekWire
August 08, 2018

How this cancer therapy went from scientific underdog to potential cure

This GeekWire article and podcast weaves together Fred Hutch expertise in bone marrow transplantation and newer cell therapies, such as CAR T. The Hutch’s Dr. Stan Riddell and Dr. David Maloney talk about how CAR T-cell immunotherapy and how it was considered a crazy idea in the 1980s.

GeekWire
August 08, 2018

Opportunities, issues and challenges for biosimilars in oncology

In an article on the future of biosimilars, biologic agents that are highly similar but not identical to approved reference biologic agents, The ASCO Post quoted extensively from a recent article by the Hutch’s Dr. Gary Lyman and colleagues in The New England Journal of Medicine.

The ASCO Post
July 25, 2018

ASCO endorses guidelines for integrative therapies during and after breast cancer treatment

Fred Hutch’s Dr. Gary Lyman is quoted in this article announcing that the American Society of Clinical Oncology now accepts certain integrative therapies for patients and survivors of breast cancer. Lyman was co-chair of the ASCO panel reviewing the clinical practice guidelines.

The ASCO Post
July 25, 2018

Childhood abuse linked to endometriosis risk

Fred Hutch’s Dr. Holly Harris is quoted in this story about a study she authored on the association between childhood physical and sexual abuse and adulthood endometriosis.

Reuters
July 25, 2018

Opportunities, issues and challenges for biosimilars in oncology

In an article on the future of biosimilars, biologic agents that are highly similar but not identical to approved reference biologic agents, The ASCO Post quoted extensively from a recent article by the Hutch’s Dr. Gary Lyman and colleagues in The New England Journal of Medicine.

The ASCO Post
July 25, 2018

ASCO endorses guidelines for integrative therapies during and after breast cancer treatment

Fred Hutch’s Dr. Gary Lyman is quoted in this article announcing that the American Society of Clinical Oncology now accepts certain integrative therapies for patients and survivors of breast cancer. Lyman was co-chair of the ASCO panel reviewing the clinical practice guidelines.

The ASCO Post
July 25, 2018

Childhood abuse linked to endometriosis risk

Fred Hutch’s Dr. Holly Harris is quoted in this story about a study she authored on the association between childhood physical and sexual abuse and adulthood endometriosis.

Reuters
July 25, 2018

Top fundraisers from Base 2 Space climb given chance to climb to top of Space Needle mast

Jean Nelson, a top-10 “Base 2 Space” stair-climber in last year’s event, is among those who got to climb to the top of the Space Needle mast. “Base 2 Space” participants ascend the 832 stairs of Seattle’s landmark, and the latest event raised more than $860,000 for Fred Hutch research.

KIRO-TV
July 24, 2018

Fred Hutch program gives Washington science teachers a chance to hone their lab skills

This story profiles the experience of two high school science teachers, participating in Fred Hutch’s Science Education Partnership. The program pairs science teachers with Fred Hutch researchers to gain skills and expertise to bring into the classroom.

KNKX-FM
July 23, 2018

Is Station 31 making Seattle firefighters sick? Study hopes to find answers about ‘Cancer House’

Fred Hutch researchers are working with the city of Seattle to investigate whether firefighters at Station 31 have higher cancer rates than those at other stations. Designed to answer longstanding questions, the study is expected to conclude by summer 2019.

The Seattle Times
July 11, 2018

How does sleep influence cancer risk?

Dr. Amanda Phipps provided comment in this story, examining the links of sleep and cancer. Phipps notes “from a biological perspective, there are a lot of good reasons for us to suspect that insufficient sleep, chronic sleep debt or short sleep duration could have an impact on the development of cancer."

U.S. News & World Report
July 04, 2018

Fred Hutch study: Nanoparticles could help cutting-edge therapies get inside solid tumors

Fred Hutch researchers led by Dr. Matthias Stephan used nanoparticles to deliver two drugs directly into solid tumors to shut down the tumors’ defense mechanisms and rally the immune system. Although this was a preclinical study, not done in human patients, it opens the possibility that chimeric antigen receptor (CAR) T-cell therapies could be used not just in blood cancers but also in solid tumors. The drugs would precondition the patient and the tumor so the T cells would work better, Stephan said.

GeekWire
July 02, 2018

Fred Hutch report plots the nexus of cost and quality

This article published by Managed Care, focuses on the “Community Cancer Care in Washington State: Quality and Cost Report” recently released by the Hutch’s health care economics group, HICOR. “Committing to transparency as a catalyst for improvement, 27 hospital systems and cancer centers across Washington State bare all in the first public report to integrate clinic-level quality and cost data in oncology,” the article said.

Managed Care
July 02, 2018

Clinical trial inclusion, specialist collaboration can improve cancer outcomes for those with HIV

Drs. Jeffrey Schouten and Thomas Uldrick were interviewed for a cover story on HIV and cancer for Healio’s HemOnc Today. “How to prevent cancer in people with HIV and oncogenic viral infections, and how to diagnose the resultant cancers early so that treatment outcomes are improved, are important issues that need to be addressed for patients,” Schouten said.

Healio
June 26, 2018

Fred Hutch study finds genetic cause of aggressive brain cancer

Fred Hutch physician-scientist Dr. Eric Holland, senior vice president and director of the Human Biology Division, led a study that found that a subset of brain cancers called ependymomas can be traced back to a single, catastrophic mutation in a patient’s DNA. “It looks like a region of the DNA blew up,” he said. The GeekWire story also was reported on KIRO-TV.

GeekWire
June 26, 2018

Columnist shares dad’s story of long-term cancer survival

Jane Ann Morrison, a columnist with the Las Vegas Review-Journal, told readers that her 88-year-old father, Jim Morrison, a retired Boeing engineer who was diagnosed with non-Hodgkin lymphoma in 1991, was honored as a Hutch Hero at a June 14 Seattle Mariners game. “His bone marrow transplant at the center in 1993 has given my dad 25 additional years (and I predict even more),” she said.

Las Vegas Review
June 23, 2018

Two or more servings of red meat a week raises women’s risk of endometriosis by more than 50%

The U.K. newspaper Daily Mail, Yahoo! UK, ABC News Australia and other sites carried an article about Fred Hutch research published in the American Journal of Obstetrics and Gynecology suggesting that red meat intake increases estrogen levels, which can lead to endometriosis.

The Daily Mail
June 21, 2018

The Hutch’s 30-year journey to the Lake Union steam plant

Four days after the Hutch’s lease of the historic Lake Union steam plant was announced, real estate developer William Justen recounted the deal’s three-decade history.

Seattle Times
June 15, 2018

A leading oncology association says some complementary therapies helpful to women with breast cancer with HIV

Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.

Everyday Health
June 14, 2018

‘Intersections of innovation:’ Madrona director Matt McIlwain named Fred Hutch chair as more tech execs join board

New Fred Hutch Board of Trustees chair Matt McIlwain and Fred Hutch COO Steve Stadum talk about the intersection of cancer research and technology. The story also notes the new additions of board members Allan Jones, president and CEO of the Allen Institute, and Lyft CFO Brian Roberts, a former high-ranking Microsoft executive.

GeekWire
June 08, 2018

External relations director for the HIV Vaccine Trial Network profiled

“The HIV epidemic is global and our research works to make sure our solutions reach those most vulnerable,” said Steven Wakefield, president of the Pride Foundation in a feature profile. Wakefield is external relations director for the HIV Vaccine Trial Network that is headquartered at the Hutch, where he established The Legacy Project to increase racial and ethnic involvement in clinical trials.

Puget Sound Business Journal
June 07, 2018

Will there ever be a vaccine against cancer?

Dr. Seth M. Pollack, a sarcoma expert at Fred Hutch, talks about the potential for – and the challenges in – creating vaccines to treat and prevent cancer. “There almost certainly is not a universal target. The vaccine has to tell the immune system to go find something specific, but there’s nothing specific that the immune system can look for that is common to all cancers,” he said, adding that “there are some targets that are expressed by lots of cancers.”

U.S. News & World Report
June 06, 2018

Fred Hutch breast cancer researcher says study will help many women avoid chemotherapy

Dr. Jennifer Specht, a Fred Hutch breast cancer researcher, appeared live on KING 5's "Take Five" news show to provide expert commentary on a new breast cancer treatment study.

KING-TV
June 06, 2018

Fred Hutch doctor comments on reducing need for breast cancer patients to undergo chemotherapy

Research presented at the American Society of Clinical Oncology (ASCO) and published in the New England Journal of Medicine suggests that new genetic testing may make it possible for 70 percent of early-stage breast cancer patients to avoid chemotherapy. Fred Hutch’s Dr. Kevin Cheung explained the study and its implications for patients.

KOMO-TV
June 04, 2018

The high cost of cancer treatment

Dr. Gary Lyman, co-director of the Hutch’s health economics group, HICOR, was quoted extensively in an AARP article on financial toxicity associated with cancer treatment. “Recent studies we’ve done have shown high rates of bankruptcy among patients with cancer. And this has escalated over the past decade, as some of the exciting new agents that have come along have just skyrocketed,” he said.

AARP Magazine
June 02, 2018

The high cost of cancer treatment

Dr. Gary Lyman, co-director of the Hutch’s health economics group, HICOR, was quoted extensively in an AARP article on financial toxicity associated with cancer treatment. “Recent studies we’ve done have shown high rates of bankruptcy among patients with cancer. And this has escalated over the past decade, as some of the exciting new agents that have come along have just skyrocketed,” he said.

AARP Magazine
June 02, 2018

Study presented at American Society of Clinical Oncology compares US and Canadian cancer care costs

Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.

Reuters
June 01, 2018

Study presented at American Society of Clinical Oncology compares US and Canadian cancer care costs

Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.

Reuters
June 01, 2018

New promise for bone-marrow transplants

Fred Hutch’s Dr. Stephanie Lee and Dr. Colleen Delaney are quoted in a feature story on companies striving to make bone-marrow transplants safer. Delaney explained an experimental therapy called NLA101 that was developed at Fred Hutch and then spun out as the company Nohla Therapeutics. Delaney is director of Fred Hutch’s cord-blood transplant program and founder and chief medical officer at Nohla. 

The Wall Street Journal
May 28, 2018

New promise for bone-marrow transplants

Fred Hutch’s Dr. Stephanie Lee and Dr. Colleen Delaney are quoted in a feature story on companies striving to make bone-marrow transplants safer. Delaney explained an experimental therapy called NLA101 that was developed at Fred Hutch and then spun out as the company Nohla Therapeutics. Delaney is director of Fred Hutch’s cord-blood transplant program and founder and chief medical officer at Nohla. 

The Wall Street Journal
May 28, 2018

Does eating soy products increase or lower risk of breast cancer?

Dr. Marian L. Neuhouser, head of the Cancer Prevention Program at Fred Hutch, discussed possible links between soy products and breast cancer. She noted compounds found in soybeans and other plants can mimic the effects of estrogen, a prime driver of most breast cancers, but most studies have found no negative association between soy consumption and breast cancer risk.

U.S. News & World Report
May 24, 2018

Seattle writer summits Mount Everest to raise money for Fred Hutch

KOMO News, GeekWire, KING-TV, KIRO-TV and other outlets covered the achievement of Seattle biotech writer Luke Timmerman, who reached the peak of Mount Everest on May 22 in his quest to raise funds for cancer research at Fred Hutch. Coverage continued through early June with interviews with Timmerman and recaps of his expedition on KING-TV, KOMO News, and KATU-TV. He has raised about $340,000 so far.

KOMO News
May 23, 2018

Seattle writer summits Mount Everest to raise money for Fred Hutch

KOMO News, GeekWire, KING-TV, KIRO-TV and other outlets covered the achievement of Seattle biotech writer Luke Timmerman, who reached the peak of Mount Everest on May 22 in his quest to raise funds for cancer research at Fred Hutch. Coverage continued through early June with interviews with Timmerman and recaps of his expedition on KING-TV, KOMO News, and KATU-TV. He has raised about $340,000 so far.

KOMO News
May 23, 2018

Cancer patients are twice as likely to declare bankruptcy

In an Associated Press story on the financial toll that cancer treatment can take, Fred Hutch’s Dr. Veena Shankaran, of the Hutch’s health economics group, HICOR, spoke about the financial struggles faced by cancer patients. She said, “A lot of times people don’t realize there are resources available until they’ve already gone broke.” The story appeared in the Chicago Tribune, The Seattle Times, at CBS News online and in numerous other outlets.

The Associated Press
May 22, 2018

Cancer patients are twice as likely to declare bankruptcy

In an Associated Press story on the financial toll that cancer treatment can take, Fred Hutch’s Dr. Veena Shankaran, of the Hutch’s health economics group, HICOR, spoke about the financial struggles faced by cancer patients. She said, “A lot of times people don’t realize there are resources available until they’ve already gone broke.” The story appeared in the Chicago Tribune, The Seattle Times, at CBS News online and in numerous other outlets.

The Associated Press
May 22, 2018

The Hutch closes in on a cancer cure

Dr. Gary Gilliland, president and director, and others at Fred Hutch are quoted in an in-depth feature on the institution’s history and day-to-day work, especially in cancer immunotherapy. “We’re curing people. The question is: Why aren’t we curing everybody, and how do we extend those curative methods to other types of cancers that have been more recalcitrant?” Gilliland said. The magazine also published a story behind the story. Coverage was picked up by Tacoma’s News Tribune and other outlets.

The Seattle Times, Pacific NW Magazine
May 17, 2018

The Hutch closes in on a cancer cure

Dr. Gary Gilliland, president and director, and others at Fred Hutch are quoted in an in-depth feature on the institution’s history and day-to-day work, especially in cancer immunotherapy. “We’re curing people. The question is: Why aren’t we curing everybody, and how do we extend those curative methods to other types of cancers that have been more recalcitrant?” Gilliland said. The magazine also published a story behind the story. Coverage was picked up by Tacoma’s News Tribune and other outlets.

The Seattle Times, Pacific NW Magazine
May 17, 2018

Fred Hutch president named “Geek of the Year”

Gary Gilliland, president and director of Fred Hutch was named “Geek of the Year” at the 2018 GeekWire Awards presentation. In selecting Gilliland for the prestigious award, GeekWire noted, “The nationally recognized cancer center is working on some of the hottest frontiers in cancer research, namely cellular immunotherapy treatments that specifically target a patient’s unique cancer mutations. Under Gilliland’s leadership, the Hutch has recruited big names from the technology field to its board of trustees, including Microsoft CEO Satya Nadella and Mike Clayville, a vice president at Amazon Web Services.” Mentioned as one of the most touching moments of the evening was when Gilliland asked his fellow nominees to share the stage with him.

GeekWire
May 10, 2018

Fred Hutch president named “Geek of the Year”

Gary Gilliland, president and director of Fred Hutch was named “Geek of the Year” at the 2018 GeekWire Awards presentation. In selecting Gilliland for the prestigious award, GeekWire noted, “The nationally recognized cancer center is working on some of the hottest frontiers in cancer research, namely cellular immunotherapy treatments that specifically target a patient’s unique cancer mutations. Under Gilliland’s leadership, the Hutch has recruited big names from the technology field to its board of trustees, including Microsoft CEO Satya Nadella and Mike Clayville, a vice president at Amazon Web Services.” Mentioned as one of the most touching moments of the evening was when Gilliland asked his fellow nominees to share the stage with him.

GeekWire
May 10, 2018

Artificial intelligence takes scientists inside living human cells

A 3D model of a living human cell – the newly unveiled Allen Integrated Cell – could help scientists solve many medical mysteries. Fred Hutch molecular biologist Roger Brent, who has been using the tool for several months, said, “This lets you see things with a simple microscope that are going to be helpful to researchers all over the world – including in less affluent places.”

NPR
May 09, 2018

Artificial intelligence takes scientists inside living human cells

A 3D model of a living human cell – the newly unveiled Allen Integrated Cell – could help scientists solve many medical mysteries. Fred Hutch molecular biologist Roger Brent, who has been using the tool for several months, said, “This lets you see things with a simple microscope that are going to be helpful to researchers all over the world – including in less affluent places.”

NPR
May 09, 2018

Experts have new advice on prostate cancer screening. Here’s why they put it back on the table

Ruth Etzioni, a biostatistician in the Public Health Sciences Division, commented on prostate cancer screening recommendations issued by the U.S. Preventive Services Task Force on how men can judge whether testing is right for them. “It means the benefits and harms of the decision are going to be different for different people. Screening might be a good decision for you, but your friend may come up with a different decision, she said. The LA Times article also appeared in The Seattle Times and other outlets.

Los Angeles Times
May 08, 2018

Experts have new advice on prostate cancer screening. Here’s why they put it back on the table

Ruth Etzioni, a biostatistician in the Public Health Sciences Division, commented on prostate cancer screening recommendations issued by the U.S. Preventive Services Task Force on how men can judge whether testing is right for them. “It means the benefits and harms of the decision are going to be different for different people. Screening might be a good decision for you, but your friend may come up with a different decision, she said. The LA Times article also appeared in The Seattle Times and other outlets.

Los Angeles Times
May 08, 2018

Microsoft partners with Fred Hutch to tackle chemotherapy side effects using new AI tech

Fred Hutch and Microsoft are working together to reduce the side effects of chemotherapy and the emergency room visits that result. “They’ve unveiled a new pilot program that will leverage Microsoft’s artificial intelligence technology and Fred Hutch’s clinical and data science expertise,” said a story in GeekWire. The story also appeared on KIRO-TV.

GeekWire
May 07, 2018

Microsoft partners with Fred Hutch to tackle chemotherapy side effects using new AI tech

Fred Hutch and Microsoft are working together to reduce the side effects of chemotherapy and the emergency room visits that result. “They’ve unveiled a new pilot program that will leverage Microsoft’s artificial intelligence technology and Fred Hutch’s clinical and data science expertise,” said a story in GeekWire. The story also appeared on KIRO-TV.

GeekWire
May 07, 2018

Seattle skyline to glows orange for Fred Hutch’s efforts to battle cancer

The Seattle Times noted that landmarks across Seattle would glow orange for several nights during the week of May 7 to bring attention to Fred Hutch’s annual Obliteride bike ride that raises money to fight cancer. The event, which will be on Aug. 11, has brought in $12 million since it started. The story also was covered by KZJO-TV, KING-TV, KOMO-TV and KCPQ-TV.

The Seattle Times
May 04, 2018

Seattle skyline to glows orange for Fred Hutch’s efforts to battle cancer

The Seattle Times noted that landmarks across Seattle would glow orange for several nights during the week of May 7 to bring attention to Fred Hutch’s annual Obliteride bike ride that raises money to fight cancer. The event, which will be on Aug. 11, has brought in $12 million since it started. The story also was covered by KZJO-TV, KING-TV, KOMO-TV and KCPQ-TV.

The Seattle Times
May 04, 2018

Fred Hutch report aims to improve quality and costs of cancer care

Dr. Gary Gilliland, Fred Hutch president and director, was quoted in an article about the release of the Community Cancer Care in Washington State: Quality and Cost Report. “Participants in this endeavor can use it to learn where their efforts to improve quality and control costs are working most efficiently, and where they are not,” he said in a blog post, according to the article. The Hutchinson Institute for Cancer Outcomes Research worked on the report for five years, collecting data in partnership with providers and insurers.

Puget Sound Business Journal
May 03, 2018

Fred Hutch report aims to improve quality and costs of cancer care

Dr. Gary Gilliland, Fred Hutch president and director, was quoted in an article about the release of the Community Cancer Care in Washington State: Quality and Cost Report. “Participants in this endeavor can use it to learn where their efforts to improve quality and control costs are working most efficiently, and where they are not,” he said in a blog post, according to the article. The Hutchinson Institute for Cancer Outcomes Research worked on the report for five years, collecting data in partnership with providers and insurers.

Puget Sound Business Journal
May 03, 2018

Gene editing shows promise in combating HIV reservoirs

FierceBiotech and other outlets reported on a study published by Drs. Christopher Peterson and Hans-Peter Kiem of the Fred Hutch Clinical Research Division about a gene editing technique studied in non-human primates that may one day help fight HIV in people.

FierceBiotech
April 20, 2018

Gene editing shows promise in combating HIV reservoirs

FierceBiotech and other outlets reported on a study published by Drs. Christopher Peterson and Hans-Peter Kiem of the Fred Hutch Clinical Research Division about a gene editing technique studied in non-human primates that may one day help fight HIV in people.

FierceBiotech
April 20, 2018

Fred Hutch researcher among scientists receiving new funding to map every cell in the body

The Chan Zuckerberg Initiative announced a new infusion of funding in support of scientists working on the Human Cell Atlas, including Fred Hutch researcher Raphael Gottardo, a member of the Vaccine and Infectious Disease Division and the Public Health Sciences Division. The project to map every cell in the human body is part of the $3 billion Chan Zuckerberg Initiative, the philanthropic organization of Facebook founder Mark Zuckerberg and his wife Priscilla Chan, according to GeekWire.

GeekWire
April 19, 2018

Fred Hutch researcher among scientists receiving new funding to map every cell in the body

The Chan Zuckerberg Initiative announced a new infusion of funding in support of scientists working on the Human Cell Atlas, including Fred Hutch researcher Raphael Gottardo, a member of the Vaccine and Infectious Disease Division and the Public Health Sciences Division. The project to map every cell in the human body is part of the $3 billion Chan Zuckerberg Initiative, the philanthropic organization of Facebook founder Mark Zuckerberg and his wife Priscilla Chan, according to GeekWire.

GeekWire
April 19, 2018

CRISPR trials are about to begin in people — but we still don’t know how well it works in monkeys

Dr. Hans-Peter Kiem, a Fred Hutch oncologist, stem cell and gene therapy researcher, is quoted in this story about the gene-editing tool CRISPR, which may allow doctors to cure some diseases by altering a patient’s DNA. “Since monkeys are so similar to humans, I don’t think there’s going to be a huge challenge in translating this work to humans,” he said.

MIT Technology Review
April 11, 2018

CRISPR trials are about to begin in people — but we still don’t know how well it works in monkeys

Dr. Hans-Peter Kiem, a Fred Hutch oncologist, stem cell and gene therapy researcher, is quoted in this story about the gene-editing tool CRISPR, which may allow doctors to cure some diseases by altering a patient’s DNA. “Since monkeys are so similar to humans, I don’t think there’s going to be a huge challenge in translating this work to humans,” he said.

MIT Technology Review
April 11, 2018

Preventive benefit of finasteride for prostate cancer maintained for 16 years

A new study found that men who took finasteride for seven years had reduced risk for prostate cancer throughout 16 years of follow-up. “One concern with these kinds of interventions is that while people are taking the intervention that prostate cancer may be prevented, but then rates snap back once the intervention is discontinued. That did not happen here. The preventive benefit of finasteride was maintained over the 16 years,” said Dr. Joseph Unger, assistant member of the Cancer Prevention Program.

Cancer Therapy Advisor
April 09, 2018

Preventive benefit of finasteride for prostate cancer maintained for 16 years

A new study found that men who took finasteride for seven years had reduced risk for prostate cancer throughout 16 years of follow-up. “One concern with these kinds of interventions is that while people are taking the intervention that prostate cancer may be prevented, but then rates snap back once the intervention is discontinued. That did not happen here. The preventive benefit of finasteride was maintained over the 16 years,” said Dr. Joseph Unger, assistant member of the Cancer Prevention Program.

Cancer Therapy Advisor
April 09, 2018

News of Note—I-O in ovarian cancer; a single target for pain, obesity and depression

FierceBiotech highlighted work conducted by Dr. Kristin Anderson in Dr. Phil Greenberg’s lab on immunotherapy in ovarian cancer. The results, which were presented at the 2019 American Association for Cancer Research annual meeting showed that when combining engineered T cells with two other immune boosting treatments, the growth of ovarian tumors in mice was decreased.

FierceBiotech
April 01, 2018

News of Note—I-O in ovarian cancer; a single target for pain, obesity and depression

FierceBiotech highlighted work conducted by Dr. Kristin Anderson in Dr. Phil Greenberg’s lab on immunotherapy in ovarian cancer. The results, which were presented at the 2019 American Association for Cancer Research annual meeting showed that when combining engineered T cells with two other immune boosting treatments, the growth of ovarian tumors in mice was decreased.

FierceBiotech
April 01, 2018

It’s possible for women to have male DNA in their bodies, but there’s no need for alarm

A story that went viral in 2017 launched a wave of inaccurate stories about women acquiring male DNA from sexual partners. Not true, said Dr. J. Lee Nelson, a Fred Hutch autoimmunity researcher and rheumatologist. She explained that the most common source of male DNA in adult women is from prior pregnancy with a male child and how the mixing of DNA could benefit health.

INSIDER
March 28, 2018

It’s possible for women to have male DNA in their bodies, but there’s no need for alarm

A story that went viral in 2017 launched a wave of inaccurate stories about women acquiring male DNA from sexual partners. Not true, said Dr. J. Lee Nelson, a Fred Hutch autoimmunity researcher and rheumatologist. She explained that the most common source of male DNA in adult women is from prior pregnancy with a male child and how the mixing of DNA could benefit health.

INSIDER
March 28, 2018

Dr. Gary Lyman sees knowledge of biosimilars in cancer has improved

Fred Hutch Dr. Gary Lyman discussed the role of biosimilars and their growing use in cancer treatment.

American Journal of Managed Care
March 24, 2018

Dr. Gary Lyman sees knowledge of biosimilars in cancer has improved

Fred Hutch Dr. Gary Lyman discussed the role of biosimilars and their growing use in cancer treatment.

American Journal of Managed Care
March 24, 2018

Can we gene-edit herpes away?

Dr. Keith Jerome, a virologist at Fred Hutch, co-authored a 2016 study about gene editing in herpes-infected mice. “His is the first study to show that gene-editing technology can reach the latent virus in a nerve cell, and the first to use that technology to damage some of the virus’ DNA,” according to a Smithsonian.com article on this and other efforts to combat the virus in humans.

Smithsonian.com
March 23, 2018

Can we gene-edit herpes away?

Dr. Keith Jerome, a virologist at Fred Hutch, co-authored a 2016 study about gene editing in herpes-infected mice. “His is the first study to show that gene-editing technology can reach the latent virus in a nerve cell, and the first to use that technology to damage some of the virus’ DNA,” according to a Smithsonian.com article on this and other efforts to combat the virus in humans.

Smithsonian.com
March 23, 2018

Fred Hutch president applauds Amazon’s health care partnership

Dr. Gary Gilliland, Fred Hutch president and director, said the Amazon-JPMorgan Chase-Berkshire Hathaway partnership aimed at driving down health care costs could help change the industry for the better, but it won’t be easy because this is new territory for the companies and there are many complexities to confront.

Puget Sound Business Journal
March 21, 2018

Fred Hutch president applauds Amazon’s health care partnership

Dr. Gary Gilliland, Fred Hutch president and director, said the Amazon-JPMorgan Chase-Berkshire Hathaway partnership aimed at driving down health care costs could help change the industry for the better, but it won’t be easy because this is new territory for the companies and there are many complexities to confront.

Puget Sound Business Journal
March 21, 2018

Racial minorities with hematologic cancers receive more aggressive end-of-life care

Dr. Kedar Kirtane, a fellow in the Hematology/Oncology Fellowship Program at Fred Hutch discussed a retrospective study he and colleagues conducted that found that racial minorities with blood cancers had lower rates of advance directives and received significantly more aggressive care than white patients. Kirtane said providers need to do a better job of discussing palliative care and advanced care planning, especially for historically disadvantaged groups.

Healio
March 20, 2018

Racial minorities with hematologic cancers receive more aggressive end-of-life care

Dr. Kedar Kirtane, a fellow in the Hematology/Oncology Fellowship Program at Fred Hutch discussed a retrospective study he and colleagues conducted that found that racial minorities with blood cancers had lower rates of advance directives and received significantly more aggressive care than white patients. Kirtane said providers need to do a better job of discussing palliative care and advanced care planning, especially for historically disadvantaged groups.

Healio
March 20, 2018

Robert W. Day, former president of Fred Hutchinson, dies at 87

In a tribute, Dr. Gary Gilliland talked about working with Dr. Robert W. Day and the last accomplishments the former president made, including moving the Fred Hutch campus to its current location in South Lake Union.

The Cancer Letter
January 12, 2018

Robert W. Day, former president of Fred Hutchinson, dies at 87

In a tribute, Dr. Gary Gilliland talked about working with Dr. Robert W. Day and the last accomplishments the former president made, including moving the Fred Hutch campus to its current location in South Lake Union.

The Cancer Letter
January 12, 2018

Microsoft invests in Fred Hutch spinoff to detect diseases at earliest stages

Microsoft will partner with Adaptive Biotechnologies, which was formed in 2009 with Fred Hutch technology, to develop blood tests that will “alert doctors when people are fighting specific diseases.

Microsoft invests in Fred Hutch spinoff to detect diseases at earliest stages
January 04, 2018

Microsoft invests in Fred Hutch spinoff to detect diseases at earliest stages

Microsoft will partner with Adaptive Biotechnologies, which was formed in 2009 with Fred Hutch technology, to develop blood tests that will “alert doctors when people are fighting specific diseases.

Microsoft invests in Fred Hutch spinoff to detect diseases at earliest stages
January 04, 2018

Experiences and influences that shaped a career in cancer research

In an American Society of Hematology Q&A, Hutch president and director Dr. Gary Gilliland talks about the people and events that inspired him to become a doctor and specialize in hematology.

ASH Clinical News
January 01, 2018

Working to reduce cancer deaths in black women

In a story featuring Bridgette Hempstead, founder of the Cierra Sisters, a support group for black women with breast cancer, Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, said there is a common and false misconception that nothing can be done about a breast cancer diagnosis.

KIRO-TV
January 01, 2018

Working to reduce cancer deaths in black women

In a story featuring Bridgette Hempstead, founder of the Cierra Sisters, a support group for black women with breast cancer, Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, said there is a common and false misconception that nothing can be done about a breast cancer diagnosis.

KIRO-TV
January 01, 2018

Experiences and influences that shaped a career in cancer research

In an American Society of Hematology Q&A, Hutch president and director Dr. Gary Gilliland talks about the people and events that inspired him to become a doctor and specialize in hematology.

ASH Clinical News
January 01, 2018

New targets, diseases for CAR T-cell therapy – but expansion to solid tumors remains problematic

In an article on chimeric antigen receptor T-cell therapy, Dr. Brian Till, in the Hutch’s Clinical Research Division, discussed the practicality of using two different CAR T cells to attack two antigens – CD19 and CD20 – in lymphoma, and said the solid tumor microenvironment is more hostile to T cells.

MedPage
December 30, 2017

New targets, diseases for CAR T-cell therapy – but expansion to solid tumors remains problematic

In an article on chimeric antigen receptor T-cell therapy, Dr. Brian Till, in the Hutch’s Clinical Research Division, discussed the practicality of using two different CAR T cells to attack two antigens – CD19 and CD20 – in lymphoma, and said the solid tumor microenvironment is more hostile to T cells.

MedPage
December 30, 2017

Cognitive behavioral therapy may improve sleep during menopause

For women experiencing sleep disturbances associated with menopause, talking with a sleep coach and adopting personalized advice and tools was more effective than other measures aimed at improving sleep, according to Dr. Katherine Guthrie of the Public Health Sciences Division, who led a study that appeared in the journal Sleep.

Reuters and others
December 29, 2017

Cognitive behavioral therapy may improve sleep during menopause

For women experiencing sleep disturbances associated with menopause, talking with a sleep coach and adopting personalized advice and tools was more effective than other measures aimed at improving sleep, according to Dr. Katherine Guthrie of the Public Health Sciences Division, who led a study that appeared in the journal Sleep.

Reuters and others
December 29, 2017

Hutch doctor helps dispel breast cancer myths

Getting regular exercise is one way to improve the odds against breast cancer. For women who need to get started, Dr. Anne McTiernan, cancer prevention researcher, suggests starting slowly and working up, choosing an enjoyable form of exercise.

Good Housekeeping
December 27, 2017

Hutch doctor helps dispel breast cancer myths

Getting regular exercise is one way to improve the odds against breast cancer. For women who need to get started, Dr. Anne McTiernan, cancer prevention researcher, suggests starting slowly and working up, choosing an enjoyable form of exercise.

Good Housekeeping
December 27, 2017

Questions about vitamin D and calcium supplements for bone health in the elderly

A new study says vitamin D and calcium supplements may not help in preventing bone fractures in the elderly, but Dr. Anne McTiernan
, a Fred Hutch expert on diet and cancer, questions the doses given in the studies and notes that other research suggests that vitamin D may lower some cancer risk factors.

Seattle Times
December 26, 2017

Vaccine for sarcoma reprograms the immune system

Dr. Seth Pollack of the Clinical Research Division said an experimental drug that reprograms the immune system to fight sarcoma cells appears to be helping patients live longer with few side effects. A Phase 3 clinical trial will launch soon.

KSAT-TV (San Antonio ABC affiliate) – Ivanhoe Newswire Story
December 26, 2017

Questions about vitamin D and calcium supplements for bone health in the elderly

A new study says vitamin D and calcium supplements may not help in preventing bone fractures in the elderly, but Dr. Anne McTiernan
, a Fred Hutch expert on diet and cancer, questions the doses given in the studies and notes that other research suggests that vitamin D may lower some cancer risk factors.

Seattle Times
December 26, 2017

Vaccine for sarcoma reprograms the immune system

Dr. Seth Pollack of the Clinical Research Division said an experimental drug that reprograms the immune system to fight sarcoma cells appears to be helping patients live longer with few side effects. A Phase 3 clinical trial will launch soon.

KSAT-TV (San Antonio ABC affiliate) – Ivanhoe Newswire Story
December 26, 2017

Cancer survivors must remain vigilant throughout their lifetimes

In a commentary in JAMA Oncology, Dr. Nancy E. Davidson, senior vice president and director of the Clinical Research Division, said cancer survivors and their doctors should follow surveillance guidelines because there is no guarantee that a patient successfully treated for one cancer is not at risk for another.

New York Times
December 25, 2017

Cancer survivors must remain vigilant throughout their lifetimes

In a commentary in JAMA Oncology, Dr. Nancy E. Davidson, senior vice president and director of the Clinical Research Division, said cancer survivors and their doctors should follow surveillance guidelines because there is no guarantee that a patient successfully treated for one cancer is not at risk for another.

New York Times
December 25, 2017

The next generation of T-cell therapies takes on solid tumors

Dr. Matthias Stephan explained that experimental technology developed at Fred Hutch aims to make T-cell therapies more easily produced and more affordable.

Nature Outlook
December 20, 2017

The next generation of T-cell therapies takes on solid tumors

Dr. Matthias Stephan explained that experimental technology developed at Fred Hutch aims to make T-cell therapies more easily produced and more affordable.

Nature Outlook
December 20, 2017

Specialized CAR T-cell product targets aggressive B-cell lymphoma

In an article on chimeric antigen receptor T-cell therapy, Dr. Brian Till, in the Hutch’s Clinical Research Division, discussed the practicality of using two different CAR T cells to attack two antigens – CD19 and CD20 – in lymphoma, and said the solid tumor microenvironment is more hostile to T cells.

OncLive
December 19, 2017

Specialized CAR T-cell product targets aggressive B-cell lymphoma

In an article on chimeric antigen receptor T-cell therapy, Dr. Brian Till, in the Hutch’s Clinical Research Division, discussed the practicality of using two different CAR T cells to attack two antigens – CD19 and CD20 – in lymphoma, and said the solid tumor microenvironment is more hostile to T cells.

OncLive
December 19, 2017

Fred Hutch doctor turned a radical idea into a cancer cure

Local NPR affiliate KUOW profiles Dr. E. Donnall Thomas' pioneering work on bone marrow transplant and how it set the stage for the Seattle biotech industry.

KUOW
November 17, 2017

Fred Hutch doctor turned a radical idea into a cancer cure

Local NPR affiliate KUOW profiles Dr. E. Donnall Thomas' pioneering work on bone marrow transplant and how it set the stage for the Seattle biotech industry.

KUOW
November 17, 2017

Researchers on racial disparity: ‘We are failing black women with breast cancer’

In a Seattle Times opinion article on racial disparities in treatment and outcomes, Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, and Dr. Beti Thompson, director of the Health Disparities Research Center, said clinical trials often fail to include people of color, and black women have too little access to information and services.

Seattle Times
October 31, 2017

Researchers on racial disparity: ‘We are failing black women with breast cancer’

In a Seattle Times opinion article on racial disparities in treatment and outcomes, Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, and Dr. Beti Thompson, director of the Health Disparities Research Center, said clinical trials often fail to include people of color, and black women have too little access to information and services.

Seattle Times
October 31, 2017

Many women with breast cancer get too much testing and treatment

Dr. Scott Ramsey and Dr. Gary Lyman, leaders of the Hutchinson Institute for Cancer Outcomes Research, were quoted in an NPR story on expensive, painful and unnecessary tests and treatments that many women with breast cancer endure. This story originally appeared in Kaiser Health News.

NPR
October 21, 2017

Many women with breast cancer get too much testing and treatment

Dr. Scott Ramsey and Dr. Gary Lyman, leaders of the Hutchinson Institute for Cancer Outcomes Research, were quoted in an NPR story on expensive, painful and unnecessary tests and treatments that many women with breast cancer endure. This story originally appeared in Kaiser Health News.

NPR
October 21, 2017

FDA approves another amazing and costly cancer-killing gene therapy

Dr. David Maloney of Fred Hutch commented on the FDA approval of a CAR T-cell treatment for lymphoma and the promise the immunotherapy has for saving lives.

Forbes
October 18, 2017

FDA approves another amazing and costly cancer-killing gene therapy

Dr. David Maloney of Fred Hutch commented on the FDA approval of a CAR T-cell treatment for lymphoma and the promise the immunotherapy has for saving lives.

Forbes
October 18, 2017

Cancer researchers learn more about toxic side effects of new treatments

Fred Hutch researchers led by Dr. Cameron Turtle published detailed descriptions on the two most common side effects of CAR T-cell therapy, to better understand which patients are most vulnerable and how to prevent the effects.

Washington Post
October 12, 2017

Cancer researchers learn more about toxic side effects of new treatments

Fred Hutch researchers led by Dr. Cameron Turtle published detailed descriptions on the two most common side effects of CAR T-cell therapy, to better understand which patients are most vulnerable and how to prevent the effects.

Washington Post
October 12, 2017

Fred Hutch director: We can cure cancer by 2025

NBC affiliate shared footage of Dr. Gary Gilliland's appearance at the 2017 GeekWire Summit during which he spoke about how technology has a role in cancer cures.

KING5
October 10, 2017

Future battles against cancer will expand tech frontiers, Fred Hutch’s chief says

Dr. Gary Gilliland discussed his prediction for cancer cures by 2025 and the importance of the technology and data science communities in making that goal a reality. He spoke at the 2017 GeekWire Summit.

GeekWire
October 10, 2017

Fred Hutch director: We can cure cancer by 2025

NBC affiliate shared footage of Dr. Gary Gilliland's appearance at the 2017 GeekWire Summit during which he spoke about how technology has a role in cancer cures.

KING5
October 10, 2017

Future battles against cancer will expand tech frontiers, Fred Hutch’s chief says

Dr. Gary Gilliland discussed his prediction for cancer cures by 2025 and the importance of the technology and data science communities in making that goal a reality. He spoke at the 2017 GeekWire Summit.

GeekWire
October 10, 2017

Lymphoma physician-scientist Oliver Press, MD, PhD, dies at 65

Blood cancer physician-scientist Dr. Oliver Press of Fred Hutch made foundational contributions to the development of targeted cancer therapies. He died Sept. 29 of complications from glioma.

The ASCO Post
October 04, 2017

Immunotherapy combinations offer hope in glioblastoma

Dr. Eric Holland discussed the challenges in treating glioblastoma and the importance of understanding the biology of the disease and developing targeted treatments that involve immunotherapy.

OncLive
October 04, 2017

Innovator of the Month: Blaze Bioscience uses scorpion venom to light up cancer tumors

Fred Hutch spinout, Blaze Bioscience, is featured as innovator of the month for its "tumor paint" technology which was developed in the lab of Dr. Jim Olson.

Puget Sound Business Journal
October 04, 2017

Lymphoma physician-scientist Oliver Press, MD, PhD, dies at 65

Blood cancer physician-scientist Dr. Oliver Press of Fred Hutch made foundational contributions to the development of targeted cancer therapies. He died Sept. 29 of complications from glioma.

The ASCO Post
October 04, 2017

Immunotherapy combinations offer hope in glioblastoma

Dr. Eric Holland discussed the challenges in treating glioblastoma and the importance of understanding the biology of the disease and developing targeted treatments that involve immunotherapy.

OncLive
October 04, 2017

Innovator of the Month: Blaze Bioscience uses scorpion venom to light up cancer tumors

Fred Hutch spinout, Blaze Bioscience, is featured as innovator of the month for its "tumor paint" technology which was developed in the lab of Dr. Jim Olson.

Puget Sound Business Journal
October 04, 2017

Why Fred Hutch President Gary Gilliland is enlisting techies to defeat cancer by 2025

Article featuring Dr. Gary Gilliland discussing how Fred Hutch is bringing big-data experts on board to make good on his prediction that there could be cures and therapies for, "most, if not all, human cancers" by 2025.

GeekWire
September 26, 2017

Why Fred Hutch President Gary Gilliland is enlisting techies to defeat cancer by 2025

Article featuring Dr. Gary Gilliland discussing how Fred Hutch is bringing big-data experts on board to make good on his prediction that there could be cures and therapies for, "most, if not all, human cancers" by 2025.

GeekWire
September 26, 2017

Why Fred Hutch President Gary Gilliland is enlisting techies to defeat cancer by 2025

Article featuring Dr. Gary Gilliland discussing how Fred Hutch is bringing big-data experts on board to make good on his prediction that there could be cures and therapies for, "most, if not all, human cancers" by 2025.

GeekWire
September 26, 2017

Why Fred Hutch President Gary Gilliland is enlisting techies to defeat cancer by 2025

Article featuring Dr. Gary Gilliland discussing how Fred Hutch is bringing big-data experts on board to make good on his prediction that there could be cures and therapies for, "most, if not all, human cancers" by 2025.

GeekWire
September 26, 2017

Tinkering with T cells

Dr. Brian Till gave context to CAR-T therapies for blood cancers in an article summarizing recent FDA approvals of the therapy which appeared in a magazine published by the world's oldest and largest professional organization of its kind, the American Association for Cancer Research.

Cancer Today
September 25, 2017

Tinkering with T cells

Dr. Brian Till gave context to CAR-T therapies for blood cancers in an article summarizing recent FDA approvals of the therapy which appeared in a magazine published by the world's oldest and largest professional organization of its kind, the American Association for Cancer Research.

Cancer Today
September 25, 2017

Juno Therapeutics ready for another round in war on cancer

Dr. Stanley Riddell commented on advances in CAR-T therapy for treating blood cancers and how he believes that the side effects of the therapy will be manageable. Juno is a spinout of Fred Hutch.

The Seattle Times
September 15, 2017

Juno Therapeutics ready for another round in war on cancer

Dr. Stanley Riddell commented on advances in CAR-T therapy for treating blood cancers and how he believes that the side effects of the therapy will be manageable. Juno is a spinout of Fred Hutch.

The Seattle Times
September 15, 2017

Re-analysis finds benefit in cancer screening. Should you believe it?

Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.

Forbes
September 07, 2017

Re-analysis finds benefit in cancer screening. Should you believe it?

Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.

Forbes
September 07, 2017

Do prostate cancer screenings significantly reduce deaths?

Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary. The article was republished from STAT.

Scientific American
September 05, 2017

New studies lend support for PSA screening for prostate cancer

Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.

CBS News
September 05, 2017

Do prostate cancer screenings significantly reduce deaths?

Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary. The article was republished from STAT.

Scientific American
September 05, 2017

New studies lend support for PSA screening for prostate cancer

Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.

CBS News
September 05, 2017

Prostate cancer test saves lives, risks remain

Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.

Reuters
September 04, 2017

PSA screening for prostate cancer saves lives after all, study says

Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.

Los Angeles Times
September 04, 2017

New apps help people with addictions

Dr. Jaimee Heffner was quoted in an article about using apps to help battle addiction. Heffner and colleagues developed Smart Quit, an app to assist people stop smoking, and in the article she was quoted about the benefits and complexities of the approach.

HealthLine
September 04, 2017

New study offers support for prostate testing

Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary

The New York Times
September 04, 2017

Prostate cancer test saves lives, risks remain

Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.

Reuters
September 04, 2017

PSA screening for prostate cancer saves lives after all, study says

Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.

Los Angeles Times
September 04, 2017

New apps help people with addictions

Dr. Jaimee Heffner was quoted in an article about using apps to help battle addiction. Heffner and colleagues developed Smart Quit, an app to assist people stop smoking, and in the article she was quoted about the benefits and complexities of the approach.

HealthLine
September 04, 2017

New study offers support for prostate testing

Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary

The New York Times
September 04, 2017

US clears breakthrough gene therapy for childhood leukemia

Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia

Associated Press
August 31, 2017

US clears breakthrough gene therapy for childhood leukemia

Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia

Associated Press
August 31, 2017

Hailing a breakthrough in fighting cancer, FDA approves gene therapy that functions as a ‘living drug’

Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CART cells to fight childhood leukemia

The Los Angeles Times
August 30, 2017

Landmark FDA approval clears the way for gene therapy treatments that fight cancer

Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CART cells to fight childhood leukemia

GeekWire
August 30, 2017

‘Hit-and-run’ gene therapy nanoparticles could enhance CAR-T treatments

Dr. Matthias Stephan was quoted on his study developing nanoparticle technology to streamline the manufacturing of cell therapies and make these treatments more off-the-shelf.

FierceBiotech
August 30, 2017

New ‘hit-and-run’ gene editing tool temporarily rewrites genetics to treat cancer and HIV

Dr. Matthias Stephan was quoted on his study developing nanoparticle technology to streamline the manufacturing of cell therapies and make these treatments off-the-shelf

GeekWire
August 30, 2017

Pioneering cancer gene therapy gets green light — and $475,000 price tag

Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia

Kaiser Health News
August 30, 2017

First cancer 'living drug' gets go-ahead

Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia

BBC News
August 30, 2017

Hailing a breakthrough in fighting cancer, FDA approves gene therapy that functions as a ‘living drug’

Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CART cells to fight childhood leukemia

The Los Angeles Times
August 30, 2017

Landmark FDA approval clears the way for gene therapy treatments that fight cancer

Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CART cells to fight childhood leukemia

GeekWire
August 30, 2017

‘Hit-and-run’ gene therapy nanoparticles could enhance CAR-T treatments

Dr. Matthias Stephan was quoted on his study developing nanoparticle technology to streamline the manufacturing of cell therapies and make these treatments more off-the-shelf.

FierceBiotech
August 30, 2017

New ‘hit-and-run’ gene editing tool temporarily rewrites genetics to treat cancer and HIV

Dr. Matthias Stephan was quoted on his study developing nanoparticle technology to streamline the manufacturing of cell therapies and make these treatments off-the-shelf

GeekWire
August 30, 2017

Pioneering cancer gene therapy gets green light — and $475,000 price tag

Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia

Kaiser Health News
August 30, 2017

First cancer 'living drug' gets go-ahead

Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia

BBC News
August 30, 2017

Steady may win the weight-loss race

Dr. Anne McTiernan was quoted in an article on the benefits of steady weight loss opposed to dramatic results. “Slow and steady wins the race,” she said.

Reuters
August 29, 2017

Steady may win the weight-loss race

Dr. Anne McTiernan was quoted in an article on the benefits of steady weight loss opposed to dramatic results. “Slow and steady wins the race,” she said.

Reuters
August 29, 2017

Vitamin B6 and B12 supplements appear to cause cancer in men

Article covers research from Drs. Theodore Brasky and Emily White on a link between lung cancer and long-term use of B6 and B12 dietary supplements, particularly in men.

The Atlantic
August 25, 2017

Vitamin B6 and B12 supplements appear to cause cancer in men

Article covers research from Drs. Theodore Brasky and Emily White on a link between lung cancer and long-term use of B6 and B12 dietary supplements, particularly in men.

The Atlantic
August 25, 2017

Can baby powder really cause ovarian cancer?

Dr. Robyn Anderson was quoted on links between talcum powder and ovarian cancer. Anderson commented on the potential risks of talcum powder use.

TIME
August 22, 2017

Can baby powder really cause ovarian cancer?

Dr. Robyn Anderson was quoted on links between talcum powder and ovarian cancer. Anderson commented on the potential risks of talcum powder use.

TIME
August 22, 2017

Are the health benefits of red wine actually legit?

Dr. Anne McTiernan shed light on the science behind the potential health benefits and risks of drinking red wine

SELF
August 16, 2017

Are the health benefits of red wine actually legit?

Dr. Anne McTiernan shed light on the science behind the potential health benefits and risks of drinking red wine

SELF
August 16, 2017

A cancer conundrum: too many drug trials, too few patients

Dr. Scott Ramsey, co-director of the Hutchinson Center for Cancer Outcomes Research, or HICOR, was quoted in an article about the lack of patients available to participate in immunotherapy clinical trials

The New York Times
August 12, 2017

A cancer conundrum: too many drug trials, too few patients

Dr. Scott Ramsey, co-director of the Hutchinson Center for Cancer Outcomes Research, or HICOR, was quoted in an article about the lack of patients available to participate in immunotherapy clinical trials

The New York Times
August 12, 2017

New Hutch center to focus on cancers caused by microbes

Article covers the launch of the new Pathogen-Associated Malignancy Integrated Research Center (PAM-IRC) and quotes its director, Dr. Denise Galloway

The Seattle Times
August 10, 2017

Fred Hutch takes step toward 'moonshot' goal with new pathogen-caused-cancer center

Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia

The Puget Sound Business Journal
August 10, 2017

Conquer cancer foundation researcher spotlight

Dr. Aude Chapuis was featured in a spotlight article on her career and research using T-cell therapy and checkpoint inhibitors to treat cancer

The ASCO Post
August 10, 2017

Fred Hutch unveils new research center aimed at eliminating cancers caused by infections

Article covers the launch of the new Pathogen-Associated Malignancy Integrated Research Center (PAM-IRC) and quotes its director, Dr. Denise Galloway

Geekwire
August 10, 2017

Advances in the treatment of triple-negative breast cancer

Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, was featured in an article about recent advances in the research and treatment of triple-negative breast cancer

The ASCO Post
August 10, 2017

New Hutch center to focus on cancers caused by microbes

Article covers the launch of the new Pathogen-Associated Malignancy Integrated Research Center (PAM-IRC) and quotes its director, Dr. Denise Galloway

The Seattle Times
August 10, 2017

Fred Hutch takes step toward 'moonshot' goal with new pathogen-caused-cancer center

Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia

The Puget Sound Business Journal
August 10, 2017

Conquer cancer foundation researcher spotlight

Dr. Aude Chapuis was featured in a spotlight article on her career and research using T-cell therapy and checkpoint inhibitors to treat cancer

The ASCO Post
August 10, 2017

Fred Hutch unveils new research center aimed at eliminating cancers caused by infections

Article covers the launch of the new Pathogen-Associated Malignancy Integrated Research Center (PAM-IRC) and quotes its director, Dr. Denise Galloway

Geekwire
August 10, 2017

Advances in the treatment of triple-negative breast cancer

Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, was featured in an article about recent advances in the research and treatment of triple-negative breast cancer

The ASCO Post
August 10, 2017

More than 3 million life-years added over 60 years as a result of SWOG clinical trials

An interview with Dr. Joseph Unger on the effectiveness of SWOG, a federal clinical trial consortium of which Fred Hutch is a leading member

The Cancer Letter
August 08, 2017

More than 3 million life-years added over 60 years as a result of SWOG clinical trials

An interview with Dr. Joseph Unger on the effectiveness of SWOG, a federal clinical trial consortium of which Fred Hutch is a leading member

The Cancer Letter
August 08, 2017

Antipsychotic added to ASCO antiemetic guide

Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy

MedPage
July 31, 2017

Antipsychotic added to ASCO antiemetic guide

Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy

MedPage
July 31, 2017

Antipsychotic added to ASCO antiemetic guide

Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy

MedPage
July 31, 2017

Antipsychotic added to ASCO antiemetic guide

Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy

MedPage
July 31, 2017

Taking another look at whole milk yogurt

Dr. Mario Kratz was quoted in an article on the health factors associated with nonfat and full-fat yogurt saying there were associations between all types of yogurt and health benefits

The Boston Globe
July 29, 2017

Taking another look at whole milk yogurt

Dr. Mario Kratz was quoted in an article on the health factors associated with nonfat and full-fat yogurt saying there were associations between all types of yogurt and health benefits

The Boston Globe
July 29, 2017

These experimental treatments target brain cancer like John McCain’s

Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Sen. John McCain was diagnosed with, is particularly complicated

The Washington Post
July 26, 2017

Lab etiquette: The perils of pet peeves

Nature quoted Dr. Karen Peterson in an article about laboratory etiquette and how to foster good relationships in research groups

Nature
July 26, 2017

Medicine's movable feast: What jumping genes can teach us about treating disease

Dr. Michael Emerman was quoted in an article on transposable elements in genomes that can jump around chromosomes, contribute to life-threatening diseases and come from dormant viruses

Scientific American
July 26, 2017

These experimental treatments target brain cancer like John McCain’s

Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Sen. John McCain was diagnosed with, is particularly complicated

The Washington Post
July 26, 2017

Lab etiquette: The perils of pet peeves

Nature quoted Dr. Karen Peterson in an article about laboratory etiquette and how to foster good relationships in research groups

Nature
July 26, 2017

Medicine's movable feast: What jumping genes can teach us about treating disease

Dr. Michael Emerman was quoted in an article on transposable elements in genomes that can jump around chromosomes, contribute to life-threatening diseases and come from dormant viruses

Scientific American
July 26, 2017

Brain cancer like McCain's has hundreds of experimental therapies (with little success)

Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated

Forbes
July 24, 2017

Brain cancer like McCain's has hundreds of experimental therapies (with little success)

Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated

Forbes
July 24, 2017

Why John McCain's type of brain tumor is so hard to treat

Dr. Eric Holland was quoted in an article on glioblastoma, the type of brain cancer Sen. John McCain was diagnosed with

Forbes
July 21, 2017

Why John McCain's type of brain tumor is so hard to treat

Dr. Eric Holland was quoted in an article on glioblastoma, the type of brain cancer Sen. John McCain was diagnosed with

Forbes
July 21, 2017

The future of treatment for glioblastoma

Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated

CNN
July 20, 2017

The future of treatment for glioblastoma

Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated

CNN
July 20, 2017

The future of treatment for glioblastoma

Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated

CNN
July 20, 2017

The future of treatment for glioblastoma

Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated

CNN
July 20, 2017

First Person: Rainer Storb, MD

Dr. Rainer Storb was featured in an article on his life and research. The article also quoted Dr. Brenda Sandmaier, a mentee of Storb

Cancer
July 19, 2017

First Person: Rainer Storb, MD

Dr. Rainer Storb was featured in an article on his life and research. The article also quoted Dr. Brenda Sandmaier, a mentee of Storb

Cancer
July 19, 2017

Novel cancer treatment wins endorsement of FDA advisers

Dr. David Maloney quoted in an article on the Food and Drug Administration recommendation to approve a CAR-T therapy

The Washington Post
July 17, 2017

Novel cancer treatment wins endorsement of FDA advisers

Dr. David Maloney quoted in an article on the Food and Drug Administration recommendation to approve a CAR-T therapy

The Washington Post
July 17, 2017

A stem cell transplant helped beat back a young doctor’s cancer. Now, it’s assaulting his body

An in-depth look at stem cell transplantation for leukemia and the complications that arise, highlighting Drs. Paul Martin, Marie Bleakley and Leslie Kean and the late Dr. E. Donnall Thomas and his Nobel Prize

Science
July 12, 2017

A stem cell transplant helped beat back a young doctor’s cancer. Now, it’s assaulting his body

An in-depth look at stem cell transplantation for leukemia and the complications that arise, highlighting Drs. Paul Martin, Marie Bleakley and Leslie Kean and the late Dr. E. Donnall Thomas and his Nobel Prize

Science
July 12, 2017

First gene therapy — ‘a true living drug’ — on the cusp of FDA approval

Dr. David Maloney quoted in an article on the Food and Drug Administration recommendation to approve a CAR-T therapy

The Washington Post
July 11, 2017

First gene therapy — ‘a true living drug’ — on the cusp of FDA approval

Dr. David Maloney quoted in an article on the Food and Drug Administration recommendation to approve a CAR-T therapy

The Washington Post
July 11, 2017

How children change their mothers — and their mothers’ DNA

An article on microchimerism, a process in which the placenta allows a small transfer of cells between mother and fetus during pregnancy, quoting Dr. J. Lee Nelson

The Boston Globe
July 08, 2017

How children change their mothers — and their mothers’ DNA

An article on microchimerism, a process in which the placenta allows a small transfer of cells between mother and fetus during pregnancy, quoting Dr. J. Lee Nelson

The Boston Globe
July 08, 2017

Is Alcohol Good for You? An Industry-Backed Study Seeks Answers

Dr. Anne McTiernan in an article on a new $100 million clinical trial, funded by the National Institutes of Health, to test whether small amounts of alcohol can benefit health

The New York Times
July 03, 2017

Robots are milking scorpions for venom that can be used in cancer research

An article on a robot being used to milk scorpion venom for medical research that referenced work at Fred Hutch in adapting the venom to be used as tumor paint to light up cancer cells

Wired
July 03, 2017

Is Alcohol Good for You? An Industry-Backed Study Seeks Answers

Dr. Anne McTiernan in an article on a new $100 million clinical trial, funded by the National Institutes of Health, to test whether small amounts of alcohol can benefit health

The New York Times
July 03, 2017

Robots are milking scorpions for venom that can be used in cancer research

An article on a robot being used to milk scorpion venom for medical research that referenced work at Fred Hutch in adapting the venom to be used as tumor paint to light up cancer cells

Wired
July 03, 2017

Health Tech Podcast: Psychologists become app developers to help people kick addictions

Article on work by Drs. Jonathan Bricker and Jaimee Heffner on fighting smoking addiction with their app, SmartQuit

GeekWire
June 29, 2017

Health Tech Podcast: Psychologists become app developers to help people kick addictions

Article on work by Drs. Jonathan Bricker and Jaimee Heffner on fighting smoking addiction with their app, SmartQuit

GeekWire
June 29, 2017

Amazon CEO Jeff Bezos is searching for philanthropic ideas

Article about Jeff Bezos' approach to philanthropy notes the Bezos family's generous philanthropic support of Fred Hutch

CNET
June 27, 2017

Scientists are using decade-old snot to combat the flu

An article on research from Dr. Jesse Bloom and Katherine Xue about how the evolution of the influenza virus in an individual could shed light on the evolution of future virus strains

The Week
June 27, 2017

National project led by Fred Hutch researcher fights ovarian cancer deaths with predictive medicine

Article on a new initiative by the National Cancer Institute co-led by Dr. Amanda Paulovich to identify the best treatment for patients with ovarian cancer

GeekWire
June 27, 2017

A clever new way to predict next year's flu

An article on research from Dr. Jesse Bloom and Katherine Xue about how the evolution of the influenza virus in an individual could shed light on the evolution of future virus strains

The Atlantic
June 27, 2017

National project led by Fred Hutch researcher fights ovarian cancer deaths with predictive medicine

Article on a new initiative by the National Cancer Institute co-led by Dr. Amanda Paulovich to identify the best treatment for patients with ovarian cancer

GeekWire
June 27, 2017

Is working at night healthy? Late shifts may increase risk of cancer and lead to poor health

An article covers work from Dr. Parveen Bhatti on the potentially harmful effects of working night shifts

Newsweek
June 27, 2017

Could shift work damage your DNA?

An article covers work from Dr. Parveen Bhatti on the potentially harmful effects of working night shifts

WebMD
June 27, 2017

Amazon CEO Jeff Bezos is searching for philanthropic ideas

Article about Jeff Bezos' approach to philanthropy notes the Bezos family's generous philanthropic support of Fred Hutch

CNET
June 27, 2017

Scientists are using decade-old snot to combat the flu

An article on research from Dr. Jesse Bloom and Katherine Xue about how the evolution of the influenza virus in an individual could shed light on the evolution of future virus strains

The Week
June 27, 2017

National project led by Fred Hutch researcher fights ovarian cancer deaths with predictive medicine

Article on a new initiative by the National Cancer Institute co-led by Dr. Amanda Paulovich to identify the best treatment for patients with ovarian cancer

GeekWire
June 27, 2017

A clever new way to predict next year's flu

An article on research from Dr. Jesse Bloom and Katherine Xue about how the evolution of the influenza virus in an individual could shed light on the evolution of future virus strains

The Atlantic
June 27, 2017

National project led by Fred Hutch researcher fights ovarian cancer deaths with predictive medicine

Article on a new initiative by the National Cancer Institute co-led by Dr. Amanda Paulovich to identify the best treatment for patients with ovarian cancer

GeekWire
June 27, 2017

Is working at night healthy? Late shifts may increase risk of cancer and lead to poor health

An article covers work from Dr. Parveen Bhatti on the potentially harmful effects of working night shifts

Newsweek
June 27, 2017

Could shift work damage your DNA?

An article covers work from Dr. Parveen Bhatti on the potentially harmful effects of working night shifts

WebMD
June 27, 2017

The clue to next year's flu strain could be inside you

An article on research from Dr. Jesse Bloom and Katherine Xue about how the evolution of the influenza virus in an individual could shed light on the evolution of future virus strains

Wired
June 26, 2017

The clue to next year's flu strain could be inside you

An article on research from Dr. Jesse Bloom and Katherine Xue about how the evolution of the influenza virus in an individual could shed light on the evolution of future virus strains

Wired
June 26, 2017

Fred Hutch receives $24M contract to expand National Cancer Institute Contact Center operations

Nancy Gore is quoted on the importance of operating the NCI's only call center for patients, which is housed at Fred Hutch

GeekWire
June 24, 2017

Fred Hutch receives $24M contract to expand National Cancer Institute Contact Center operations

Nancy Gore is quoted on the importance of operating the NCI's only call center for patients, which is housed at Fred Hutch

GeekWire
June 24, 2017

Young kids may have mature biases against overweight people

Dr. Anne McTiernen quoted in a story on research on whether children have a bias against overweight people early on in life

Reuters Health
June 23, 2017

Young kids may have mature biases against overweight people

Dr. Anne McTiernen quoted in a story on research on whether children have a bias against overweight people early on in life

Reuters Health
June 23, 2017

Why pancreatic cancer is such a killer, and what's being done about it

An article about the difficulties in treating pancreatic cancer and promising research advances that have been made. The story featured Fred Hutch physician-scientist Dr. Sunil Hingorani

CBS News
June 20, 2017

Coconut oil has more ‘bad’ fat than beef and butter: heart doctors

Dr. John Potter quoted in an article on an advisory from the American Heart Association on the health implications of coconut oil

Reuters
June 20, 2017

Why pancreatic cancer is such a killer, and what's being done about it

An article about the difficulties in treating pancreatic cancer and promising research advances that have been made. The story featured Fred Hutch physician-scientist Dr. Sunil Hingorani

CBS News
June 20, 2017

Coconut oil has more ‘bad’ fat than beef and butter: heart doctors

Dr. John Potter quoted in an article on an advisory from the American Heart Association on the health implications of coconut oil

Reuters
June 20, 2017

Triple therapy potent approach in aggressive skin cancer

Article covering Dr. Kelly Paulson's presentation of findings for a new treatment for Merkel cell carcinoma at the annual American Society for Clinical Oncology meeting

The Atlantic
June 19, 2017

Triple therapy potent approach in aggressive skin cancer

Article covering Dr. Kelly Paulson's presentation of findings for a new treatment for Merkel cell carcinoma at the annual American Society for Clinical Oncology meeting

The Atlantic
June 19, 2017

Study informs use of NSAID benefit in colon cancer

Article covers study led by Dr. Polly Newcomb indicating that use of nonsteroidal anti-inflammatory drugs can increase survival rate in colorectal cancer patients without KRAS wild-type tumors

Medpage Today
June 16, 2017

Biologists debate how to license preprints

Dr. Jesse Bloom is quoted on open access to scientific research and how he approaches sharing results prior to journal publication

Nature
June 16, 2017

PEGPH20 could improve metastatic pancreatic cancer outcomes

Article covers presentation by Dr. Sunil Hingorani at the annual American Society of Clinical Oncology meeting of the results in a pancreatic cancer trial

Cancer Network
June 16, 2017

Study informs use of NSAID benefit in colon cancer

Article covers study led by Dr. Polly Newcomb indicating that use of nonsteroidal anti-inflammatory drugs can increase survival rate in colorectal cancer patients without KRAS wild-type tumors

Medpage Today
June 16, 2017

Biologists debate how to license preprints

Dr. Jesse Bloom is quoted on open access to scientific research and how he approaches sharing results prior to journal publication

Nature
June 16, 2017

PEGPH20 could improve metastatic pancreatic cancer outcomes

Article covers presentation by Dr. Sunil Hingorani at the annual American Society of Clinical Oncology meeting of the results in a pancreatic cancer trial

Cancer Network
June 16, 2017

At last, Jeff Bezos offers a hint of his philanthropic plans

Article about Jeff Bezos' approach to philanthropy notes the Bezos family's generous philanthropic support of Fred Hutch

The New York Times
June 15, 2017

Jeff Bezos wants ideas for philanthropy, so he asked Twitte

Article about Jeff Bezos' approach to philanthropy notes the Bezos family's generous philanthropic support of Fred Hutch

The New York Times
June 15, 2017

At last, Jeff Bezos offers a hint of his philanthropic plans

Article about Jeff Bezos' approach to philanthropy notes the Bezos family's generous philanthropic support of Fred Hutch

The New York Times
June 15, 2017

Jeff Bezos wants ideas for philanthropy, so he asked Twitte

Article about Jeff Bezos' approach to philanthropy notes the Bezos family's generous philanthropic support of Fred Hutch

The New York Times
June 15, 2017

For experimental cancer therapy, a struggle to ensure supply keeps up with demand

Article quotes Dr. David Maloney on potential challenges of treating patients with cellular immunotherapies once they're approved for wider use

Science
June 13, 2017

For experimental cancer therapy, a struggle to ensure supply keeps up with demand

Article quotes Dr. David Maloney on potential challenges of treating patients with cellular immunotherapies once they're approved for wider use

Science
June 13, 2017